DE102008053034A1 - Use of hydroxycinnamic acids and their derivatives and / or plant extracts for the treatment of body odor - Google Patents

Abstract

The present invention relates to the use of hydroxycinnamic acids and / or their derivatives and of plant extracts selected from meadowsweet extract, St. John's Wort extract and extracts containing hydroxycinnamic acids and / or derivatives thereof for inhibiting enzymes, in particular cystathionine-beta-lyase. and / or for the prevention or treatment of body odor, in particular in the axillary area, as well as cosmetic and pharmaceutical preparations, in particular deodorants and antiperspirants, which contain these active substances.

Description

The The present invention relates to the use of hydroxycinnamic acids and / or their derivatives and plant extracts from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives to inhibit enzymes, in particular cystathionine-beta-lyase, and / or for the prevention or treatment of body odor, especially in the axillary area, as well as cosmetic and pharmaceutical Preparations, in particular deodorants and antiperspirants, containing these active ingredients.

It is now considered proven that body odor in the first place Line through the breakdown of sweat components by bacteria the skin flora, especially in the axillary area, arises. Next Perfumes for covering body odor are therefore used in deodorants to prevent body odor so far mainly unselective biocides Used to kill the bacteria in the axillary area. The Use of unselective antibacterial substances has however, the disadvantage that even bacteria that have no smell be caused, inhibited or killed. The protective function for the skin that emanates from these bacteria is going through the application thus unselective antibacterial agents destroyed. In addition, it is known that many antibacterial agents bad against body odor. Leave it conclude that by the antibacterial Active ingredients the odor-causing bacteria not or only insufficient be inhibited or that possibly connections exist in the bacterial community (eg so far unknown odor-producing species) whose effects on the Formation of body odor from the substances used not be recorded.

A similar Problem as for body odor also exists for Halitosis. Again, the starting materials are bacterial in malodorous Converted degradation products.

It There is therefore still a need to find ways to combat it Body odor, especially for the axillary and oral area, especially those which are better for body odor and / or bad breath are effective than the previously known agents, preferably without to cause an unselective antibacterial effect at the site of application.

In In this connection it is known that strongly malodorous Components of human body odor and bad breath in particular released by enzymatic reaction volatile Sulfur compounds, so-called "volatile sulfur compounds" (VSC) represent.

sulfuric Compounds come as water-soluble amino acid conjugates with the sweat on the human skin. There they will of cutaneous bacteria (especially of staphylococci and corynebacteria) released enzymatic reaction.

An enzyme that plays a key role in the release of VSCs is cystathionine beta-lyase. This enzyme breaks down VSCs from the amino acids and is therefore an important cause of the development of body odor (see Natsch et al. (2004) Chemistry and Biodiversity 1, 1058-1072 ; Troccaz et al. (2004) Chemistry and Biodiversity 1, 1022-1035 ; Starkenmann et al. (2005) Chemistry and Biodiversity 2, 705-716 ).

To find active ingredients for the prevention of body odor is therefore in WO 2006/079934 proposed to search for substances that inhibit the formation of VSC from their precursors in the presence of cystathionine beta-lyase. As such substances, in particular, molecules are mentioned in this document which are structurally similar to the precursors of the VSC, so that the mechanism of action of these substances presumably lies in a competitive blocking of the active center of cystathionine-beta-lyase.

One Advantage in the use of substances that target the enzyme activity inhibit cystathionine beta-lyase, is that a more targeted control of the cause of the odor can take place and preferably further antibacterially active on the insert Substances are possibly largely dispensed with or their Use can be at least limited.

Special Object of the present invention was therefore, for other substances to seek to target the activity of cystathionine beta-lyase inhibit and thus represent promising deodorant agents could.

When Enzyme for the detection of the inhibitory properties is suitable for example, cystathionine beta-lyase from Staphylococcus. When For example, substrate for cystathionine beta-lyase can be Benzylcysteine can be used. In the enzymatic reaction of cystylcysteine, cysteine is released, followed by can be detected with the aid of detection reagents. So forms about monobromobimane with cysteine make up a fluorescent complex, which can be detected spectrometrically. By inhibitors the activity of cystathionine beta-lyase is reduced and thereby also the amount of detectable released cysteine.

Surprisingly has now been found that by hydroxycinnamic acids, derivatives of hydroxycinnamic acids and by plant extracts, in particular through meadowsweet extract and St. John's Wort extract as well such extracts, the hydroxycinnamic acids and / or their Derivatives contain a very effective inhibition of cystathionine beta-lyase can be achieved.

One The first object of the present invention is therefore the use of at least one hydroxycinnamic acid and / or a derivative thereof and / or at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives to inhibit an enzyme, wherein the enzyme preferably a cystathionine beta-lyase and wherein the Use preferably in a cosmetic agent.

object The present invention therefore further the use of at least one hydroxycinnamic acid and / or a derivative thereof and / or at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives contain, for the prevention or treatment of body odor, especially in the axillary or oral area, the use being preferably in a cosmetic agent.

object The present invention furthermore relates to cosmetic or pharmaceutical Compositions for the treatment or prevention of body odor or halitosis containing at least one hydroxycinnamic acid and / or a derivative thereof and / or at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives.

object The present invention therefore continues to use of at least one hydroxycinnamic acid and / or a derivative thereof and / or at least one plant extract selected from Meadowsweet extract, St. John's Wort extract and extracts containing hydroxycinnamic acids and / or their derivatives, for the preparation of a cosmetic or pharmaceutical composition for the treatment or prevention of body odor, in particular in the axillary or oral area.

wobei R1 und R2 unabhängig voneinander ausgewählt sind aus Wasserstoff, C_1-6-Alkyl, Hydroxy und C_1-6-Alkoxy.Hydroxy cinnamic acids are according to the invention compounds of the general formula (I)

wherein R 1 and R 2 are independently selected from hydrogen, C _1-6 alkyl, hydroxy and C _1-6 alkoxy.

In a preferred embodiment according to the invention, the hydroxycinnamic acid is caffeic acid (R ₁ = H, R ₂ = OH), coumaric acid (R ₁ = H, R ₂ = H), ferulic acid (R ₁ = OCH ₃ , R ₂ = H) or sinapinic acid (R ₁ = OCH ₃ , R ₂ = OCH ₃ ), with caffeic acid being particularly preferred.

at the derivative of hydroxycinnamic acid is in a preferred embodiment of an ester of hydroxycinnamic acid with an alcohol, the alcohol being in a preferred one Embodiment is a polyhydroxy compound. Farther it is included in a preferred embodiment the polyhydroxy compound around the quinic acid. Especially It may be corresponding to the ester of hydroxycinnamic acid chlorogenic acid (5-O-caffeoylquinic acid, (1S) -3β- (3,4-Dihydroxycinnamoyloxy) -1a, 4a, 5a-trihydroxycyclohexancarbonsäure) or a di-caffeoylquinic acid, in particular 3,5-di-O-caffeoylquinic acid, act.

The derivative of hydroxycinnamic acid may furthermore be a hydroxycinnamic acid or an ester of hydroxycinnamic acid with an alcohol, characterized in that the compound is mono- or polysubstituted, preferably monosubstituted, disubstituted or trisubstituted, preferably selected from substituents the group consisting of C _1-6 alkyl, hydroxy, C _1-6 alkoxy, carboxy and halogen, in particular fluorine, chlorine or bromine.

at the plant extract to be used according to the invention, containing a hydroxycinnamic acid or a derivative thereof, it is in a preferred embodiment to a plant extract containing caffeic acid. The extract containing caffeic acid may be here in particular an extract of Ipomoea purga, Pyrus communis (Pear), Pyrus malus (apple), Ocimum basilicum (basil), thymus vulgaris (thyme), Teucrium scorodonia, Verbena officinalis, Artemisia dracunculus, Thymus serpyllum, Origanum vulgare, Melissa officinalis, Camellia sinensis, Gentiana lutea, Stachys officinalis or Arnica to act montana.

In a further preferred embodiment according to the invention it is the invention to be used Plant extract containing a hydroxycinnamic acid or a derivative of which contains a plant extract, chlorogenic acid contains. In the extract containing chlorogenic acid this may in particular be an extract of coffee (Coffea arabica), sunflower (Helianthus annuus), damask rose (Rosa damascena), blueberry (Vaccninium corymbosum), Pyrus malus (apple), Melissa officinalis, Camellia sinensis, Japanese honeysuckle (Lonicera japonica) or from the gutta percha tree (Eucommia ulmoides) act.

In In a particularly preferred embodiment, the invention is to be used Plant extract selected from extracts of Lonicera japonica, Arnica montana and Eucommia ulmoides and mixtures thereof. Because these extracts showed despite a relatively low content Hydroxycinnamic acids or their derivatives nonetheless extraordinary strong inhibitory effect on cystathionine beta-lyase, so it can be assumed that those contained in these extracts other components in combination with the cinnamic acids cause a synergistic effect.

In Another particularly preferred embodiment the plant extract to be used according to the invention selected from extracts of meadowsweet (Filipendula ulmaria, Spiraea ulmaria; also known as the "meadow queen" or "Waldbart") and St. John's wort (Hypericum perforatum).

The Preparation of the extracts can basically be done in any one Skilled in the art using any plant tissue and using any extraction agent. Thus, the plant extract, for example, by extraction of the entire plant, by extraction from flowers, leaves, Fruit, seeds, roots and / or by extraction from the meristem done the plant.

When Extraction agent for the preparation of said plant extracts For example, water, alcohols and mixtures thereof, oils and other suitable solvents. As alcohols, for example, lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as Ethylene glycol, propylene glycol, butylene glycol, dipropylene glycol and Glycerol in question, both as the sole extractant as well as in mixture with water. For example, plant extracts based on water / propylene glycol in the ratio 1:10 to 10: 1 proved to be particularly suitable. The extraction can be, for example be carried out in the form of steam distillation. Optionally, a dry extraction and / or a carbon dioxide extraction respectively.

The plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2-80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture. Depending on the choice of extractants, it may be preferable to stabilize the plant extract by adding a solubilizer. Suitable solubilizers are, for. B. Ethoxylation products of optionally hydrogenated vegetable and animal oils. Preferred solubilizers are ethoxylated mono-, di- and triglycerides of C _8-22 fatty acids having from 4 to 50 ethylene oxide units, e.g. Hydrogenated ethoxylated castor oil, ethoxylated fatty alcohols, olive oil ethoxylate, almond oil ethoxylate, mink oil ethoxylate, polyoxyethylene glycol capryl - / - / capric acid glycerides, polyoxyethylene glycerol monolaurate and polyoxyethylene glycol coconut fatty acid glycerides.

The plant extracts can, in a preferred embodiment according to the invention, also be applied to carriers, in particular in order to be better able to be incorporated into products. Erfindungsge suitable carriers are, for example, maltodextrin, talc and silica.

The Plant extracts are commercially available from, for example, Cosmetochem (Germany), Cognis (Germany), Symrise (Germany) or Rahn (Germany) available.

hydroxycinnamic and / or their derivatives and plant extracts from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives are preferred in erfindunsgemäßen agents in a total amount of up to 20 wt .-%, particularly preferably in a total amount of 0.001 to 10 wt .-%, in particular of 0.01 to 5 wt .-%, especially from 0.1 to 2 wt .-%, contain.

at the cosmetic or pharmaceutical according to the invention Composition can be any dosage form act, such as a solid or liquid soap, a lotion, a spray, a cream, a gel, an emulsion, a Cleaning fluid or cleansing milk, a stick, a Deodorant, an antiperspirant or an ointment and she can too contained in each of the described or other dosage forms be, for example, in a patch, especially in one Gel reservoir or matrix patch.

In a particularly preferred embodiment according to the invention it is the cosmetic or pharmaceutical composition a deodorant and / or antiperspirant. The deodorant and / or Antiperspirant here is preferably as powder, in stick form, as syndet, washing lotion, aerosol spray, pump spray, liquid or gel-like roll-on application, cream, foam, liquid or solid soap, gel or as a soaked flexible substrate in front.

When Applicators may vary depending on the application for example, pin barrel, roll-on, pump, tube, crucible, Dispenser, cloth, aerosol can or bottle can be used.

When Application site is the skin of each body area Question, especially the facial skin, the scalp, the skin the feet and hands. In a special preferred embodiment is at the application site around the skin in the axillary area. In a further particularly preferred Embodiment is at the application site around the oral area.

The Cosmetic or pharmaceutical according to the invention Composition may also contain other ingredients than those mentioned above contain. In a preferred embodiment contains at least one of the substances listed below. It can also be any combination of those listed below Contain ingredients.

Cosmetic or pharmaceutical compositions which have shown mixtures of hydroxycinnamic acids and / or their derivatives and / or of plant extracts selected from meadowsweet extract, St. John's wort extract and extracts containing hydroxycinnamic acids and / or derivatives thereof, and at least particularly preferably have proved to be particularly advantageous a substance that is prebiotic in the axillary area (as in WO2005 / 011716 or WO2005 / 092279 disclosed), in particular selected from plant extracts from Picea spp., Pinus sp., Paullinia sp., Panax sp., Lamium sp., Ribes sp., Hibiscus spec., Malva spec., Vitis spec., Daucus spec., Commiphora spec ., Simmondsia spec. or Calendula spec., Glycerinmonoalkylether, especially α-Monoalkylglycerinether having a branched or linear saturated or unsaturated, optionally hydroxylated C ₆ -C ₂₂ alkyl radical, particularly preferably 1- (2-ethylhexyl) glycerol ether, isopropyl myristate or ethyl myristate or mixtures thereof. The combination of on the one hand inhibitors of cystathionine beta-lyase and on the other hand in the axillary prebiotic active substances, on the one hand by the blocking of cystathionine beta-lyase, the formation of odor and simultaneously targeted the relationship between odor-forming and odorless bacteria in favor of odorless bacteria shifted so that a highly effective fight against body odor can be achieved.

Farther have been found to be particularly advantageous according to the invention cosmetic or pharmaceutical compositions, the mixtures of hydroxycinnamic acids and / or their derivatives and / or of plant extracts selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives, and at least one other Deodorant active ingredient, in particular an antimicrobial effective Substance, preferably an aromatic alcohol, and in one preferred embodiment additionally at least one of the aforementioned in the axillary area prebiotic contain active substances.

at the combined use of inhibitors of cystathionine beta-lyase and antimicrobial deodorants will increase both the number the odor-causing bacteria also reduces their odor-forming capacity reduced. Due to the additional presence of a prebiotic effective substance will continue the relationship between odor-causing bacteria and odor-neutral bacteria in favor the odor-neutral bacteria shifted, so that thereby a even more effective body odor control possible is. Due to the combined effect of antimicrobial effective Substances on the one hand and prebiotically active substances on the other hand, the desired bacteria are subsequently to a greater extent capable of doing so spread on the skin than this in the presence of a purely prebiotic Effects of the case would be. The remaining unwanted, because odor causing bacteria are blocked by the inhibitors the cystathionine beta-lyase is effectively prevented from odor.

According to the invention as other deodorant active ingredients are particularly suitable fragrances, Odor absorber, deodorizing ion exchanger, antimicrobial or germ-inhibiting substances, other enzyme-inhibiting substances, antioxidants and odor adsorbents.

When Odor absorbers are particularly suitable silicates. Support this at the same time the rheological properties of the invention Composition in an advantageous manner. To the invention especially preferably silicates used as odor absorbers especially phyllosilicates and among these in particular montmorillonite, Kaolinite, IIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talc. Further preferred odor absorbers are, for example Zeolites, zinc ricinoleate, cyclodextrins, certain metal oxides, such as As alumina, and chlorophyll.

Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. Preferably used are triclosan (Irgasan DP300 ^®), triethyl citrate, chlorhexidine, chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, Chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphen bromide, Ammoniumphenolsulfonat, benzalkonium halides, Benzalkoniumcetylphosphat , Benzalkonium saccharinates, benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide and methylbenzethonium chloride. Furthermore, phenol, disodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate, zinc phenolsulfonate, ketoglutaric acid, bisabolol, terpene alcohols such as. As farnesol, chlorophyllin copper complexes, carboxylic acid esters of mono-, di- and triglycerol (eg., Glycerinmonolaurat, diglycerol monocaprinate), lantibiotics and certain plant extracts (eg., Green tea and the components of lime blossom oil and chamomile oil) can be used ,

Preferred further enzyme-inhibiting substances are inhibitors for further enzymes of the axillary germ flora, which are involved in the development of body odor. These are preferably inhibitors of lipases, arylsulfatases (s. WO 01/99376 ), β-glucuronidases (s. WO 03/039505 ), 5-α-reductases and aminoacylases.

Further antibacterial deodorant agents are glycoglycerolipids, Sphingolipids (ceramides), sterols and other agents that are the Inhibit bacterial adhesion to the skin, z. B.

glycosidases Lipases, proteases, carbohydrates, di- and oligosaccharide fatty acid esters and alkylated mono- and oligosaccharides.

Also suitable as a deodorant active ingredient are water-soluble polyols selected from water-soluble diols, triols and higher-grade alcohols and also polyethylene glycols. Among the diols are C ₂ -C ₁₂ diols, in particular 1,2-propylene glycol, butylene glycols such. For example, 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentanediols, e.g. As 1,2-pentanediol, and hexanediols, z. For example, 1,6-hexanediol. Further preferred are glycerol and technical Oligoglyceringemische with an intrinsic degree of condensation of 1.5 to 10 such as technical Diglyceringemische having a Diglycerine content of 40 to 50 wt .-% or triglycerol, further 1,2,6-hexanetriol and polyethylene glycols (PEG) with a average molecular weight of 100 to 1000 daltons, for example PEG-400, PEG-600 or PEG-1000. Other suitable higher alcohols are the C ₄ , C ₅ and C ₆ monosaccharides and the corresponding sugar alcohols, eg. Mannitol or sorbitol.

wobei
R¹–R⁶ = unabhängig voneinander stehen für ein Wasserstoffatom, eine lineare oder verzweigte sowie gegebenenfalls substituierte C_1-10-Alkylgruppe oder eine lineare oder verzweigte sowie gegebenenfalls substituierte C_2-10-Alkenylgruppe, wobei die Substituenten jeweils vorzugsweise ausgewählt sind aus Hydroxy und C_1-6-Alkoxy,
R⁷–R¹¹ = unabhängig voneinander stehen für ein Wasserstoffatom, ein Halogenatom, insbesondere Chlor, oder eine lineare oder verzweigte sowie gegebenenfalls substituierte C_1-10-Alkylgruppe,
wobei die Substituenten vorzugsweise ausgewählt sind aus Hydroxy und C_1-6-Alkoxy,
insbesondere Methoxy,
m = 0 oder 1 ist,
n, o, p = unabhängig voneinander ganze Zahlen von 0 bis 10 sein können, wobei mindestens einer der Werte von n, o, p ≠ 0 ist.In a preferred embodiment, an aromatic alcohol is used as further deodorant active ingredient. The aromatic alcohol according to the invention is preferably a compound of the general formula

in which
R ¹ -R ⁶ = independently of one another represent a hydrogen atom, a linear or branched and optionally substituted C _1-10 -alkyl group or a linear or branched and optionally substituted C _2-10 -alkenyl group, wherein the substituents are each preferably selected from hydroxy and C _1-6 alkoxy,
R ⁷ -R ¹¹ = independently of one another represent a hydrogen atom, a halogen atom, in particular chlorine, or a linear or branched and optionally substituted C _1-10 -alkyl group,
where the substituents are preferably selected from hydroxy and C _1-6 -alkoxy,
especially methoxy,
m = 0 or 1,
n, o, p = can independently be integers from 0 to 10, with at least one of the values of n, o, p ≠ 0.

According to the invention preferred Aromatic alcohols of the aforementioned structure are selected from Phenoxyethanol, phenoxyisopropanol (3-phenoxy-propan-2-ol), aniseed alcohol, 2-methyl-5-phenyl-pentan-1-ol, 1,1-dimethyl-3-phenyl-propan-1-ol, Benzyl alcohol, 2-phenylethan-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2,2-dimethyl-3-phenylpropan-1-ol, 2,2-dimethyl-3- (3'-methylphenyl) -propan-1-ol, 2-ethyl-3-phenylpropan-1-ol, 2-ethyl-3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (2'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (4'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (3 ', 4'-dichlorophenyl) -2-ethyl-propan-1-ol, 2-ethyl-3- (2'-methyl-phenyl) -propan-1-ol, 2-ethyl-3- (4'-methylphenyl) -propan-1-ol, 3- (3 ', 4'-dimethylphenyl) -2-ethyl-propan-1-ol, 2-ethyl-3- (4'-methoxyphenyl) -propan-1-ol, 3- (3 ', 4'-dimethoxyphenyl) -2-ethyl-propan-1-ol, 2-allyl-3-phenylpropan-1-ol and 2-n-pentyl-3-phenylpropan-1-ol.

antioxidant Substances can oxidatively decompose the welding components counteract and inhibit odor in this way. Preferred antioxidants are imidazole and imidazole derivatives (e.g. B. urocanic acid), peptides, such as. B. D, L-carnosine, D-carnosine, L-carnosine and its derivatives (eg anserine), carotenoids, carotenes (eg, α-carotene, β-carotene, lycopene) and theirs Derivatives, lipoic acid and its derivatives (eg dihydrolipoic acid), Aurothioglucose, Propylthiouracil and other thio compounds (eg. B. thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, Glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, Methyl, ethyl, propyl, amyl, butyl, lauryl, palmitoyl, oleyl, γ-linoleyl, Cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, Distearyl thiodipropionate, thiodipropionic acid and their Derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthionine sulfoximines, Homocysteine sulfoximine, buthionine sulfone, penta-, hexa-, heptathionine sulfoximine) in very low tolerated dosages (eg pmol / kg to μmol / kg), furthermore metal chelators (eg α-hydroxy fatty acids, EDTA, EGTA, lactoferrin), humic acids, bile acid, Bile extracts, catechins, bilirubin, biliverdin and their derivatives, unsaturated fatty acids and their derivatives (eg. Gamma-linolenic acid, linoleic acid, arachidonic acid, oleic acid), Folic acid and its derivatives, hydroquinone and its derivatives (eg arbutin), ubiquinone and ubiquinol as well as their derivatives, vitamin C and its derivatives (eg ascorbyl palmitate, stearate, dipalmitate, acetate, Mg ascorbyl phosphates, sodium and magnesium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate), Isoascorbic acid and its derivatives, tocopherols and their Derivatives (eg tocopheryl acetate, linoleate, oleate and succinate, Tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50, Tocopherolan), vitamin A and derivatives (eg vitamin A palmitate), the coniferyl benzoate of benzoin, rutin, rutinic acid and their derivatives, disodium rutinyldisulfate, cinnamic acid and their derivatives, kojic acid, chitosan glycolate and salicylate, Butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiacetic acid, Nordihydroguiaretic acid, trihydroxybutyrophenone, uric acid and their derivatives, mannose and their derivatives, selenium and selenium derivatives (eg selenium methionine), stilbenes and stilbene derivatives (eg stilbene oxide, trans-stilbene oxide). According to the invention suitable derivatives (salts, esters, sugars, nucleotides, nucleosides, Peptides and lipids) and mixtures of these drugs or anhydrous plant extracts containing these antioxidants, be used.

When lipophilic, oil-soluble antioxidants from this Group are tocopherol and its derivatives, in particular tocopheryl acetate, and carotenoids as well as butylhydroxytoluene and butylhydroxyanisole prefers.

A Contains preferred composition according to the invention at least one of the aforementioned additional deodorant active ingredients, the total amount of additional deodorant agents preferably 0.1-10% by weight, preferably 0.2-7% by weight, particularly preferably 0.3-5 wt .-% and in particular 0.4-1.0 Wt .-% is.

Farther have been found to be particularly advantageous according to the invention cosmetic or pharmaceutical compositions, the mixtures of at least one hydroxycinnamic acid and / or a derivative thereof and / or at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives contain, and at least one antiperspirant active substance (antiperspirant Active ingredient), preferably further in combination with at least a prebiotically active substance and / or another Deodorant active ingredient included.

Suitable antiperspirant active substances according to the invention are, in particular, water-soluble astringent or protein-coagulating metallic salts, in particular inorganic and organic salts of aluminum, zirconium, zinc and titanium, and any desired mixtures of these salts. Antiperspirant active ingredients preferred according to the invention are selected from the aluminum chlorohydrates, in particular the aluminum chlorohydrates having the general formula [Al ₂ (OH) ₅ Cl. 2-3H ₂ O] _n , which may be present in unactivated or in activated (depolymerized) form, furthermore aluminum sesquichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or polyethylene glycol (PEG), aluminum sesquichlorohydrex PG or PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, furthermore selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, Aluminum zirconium octachlorohydrate, aluminum zirconium chlorohydrate glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine, potassium aluminum sulfate (KAl (SO ₄ ) ₂ .12H ₂ O, alum), aluminum undecylenoyl collagen amino acid, sodium aluminum lactate + aluminum sulfate, sodium aluminum chlorhydroxactate, aluminum bromohydrate, aluminum chloride, the complexes of zinc and sodium salts, the complexes of lanthanum and cerium, the aluminum salts of lipoamino acids, aluminum sulfate, aluminum lactate, aluminum chlorohydrate allantoinate, sodium aluminum chlorhydroxylactate, zinc chloride , Zinc sulfocarbolate, zinc sulfate and zirconium chlorohydrate. According to the invention, water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C. The antiperspirant active ingredients can be used as aqueous solutions.

In a particularly preferred embodiment, the inventive composition as antiperspirant comprises an astringent aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ^® Ultrafine or Micro Dry ^® SUF from Reheis, in the form of an aqueous solution as Locron ^® L from Clariant, as Chlorhydrol ^® and in activated form as ^Reach® 103 or ^Reach® 501 from Reheis. Under the name ^Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred. The use of aluminum zirconium tetrachlorohydrex glycine complexes, which are, for example, by Reheis under the name Rezal ^® 36G or Reach ^® 908 commercially, may be particularly preferred according to the invention.

Of the Antiperspirant active ingredient is in the inventive Compositions in an amount of 0.01-40 wt .-%, preferably 2-30% by weight and more preferably 5-25% by weight contain.

A composition according to the invention may also contain other and / or other plant extracts in addition to the abovementioned plant extracts which can be used according to the invention. These further and / or other plant extracts can be prepared for example by extraction of the entire plant, but also exclusively by extraction from flowers and / or leaves and / or seeds and / or other parts of plants. According to the invention, especially the extracts from the meristem, so the divisible educated tissue of the plants, and the extracts of special plants such as green tea, witch hazel, chamomile, pansy, Paeonie, aloe vera, horse chestnut, sage, willow bark, cinnamon tree (cinnamon tree), Chrysanthemums, Oak bark, Stinging nettle, Hops, Burdock root, Horsetail, Hawthorn, Lime blossom, Almonds, Spruce needles, Sandalwood, Juniper, Coconut, Kiwi, Guava, Lime, Mango, Apricot, Wheat, Melon, Orange, Grapefruit, Avocado, Rosemary, Birch, Beech shoots, meadowfoam, yarrow, quenelle, thyme, lemon balm, toadstool, marshmallow (Althaea), violets, blackcurrant leaves, coltsfoot, Fünffingerkraut, ginseng, ginger root and sweet potato are preferred as another plant extract. Algae extracts can also be used to advantage. The algae extracts used according to the invention are derived from green algae, brown algae, red algae or blue-green algae (cyanobacteria). The algae used for extraction can be obtained both from natural sources as well as by biotechnological processes and, if desired, be modified from the natural form. The alteration of the organisms may be by genetic engineering, by breeding or by cultivation in media enriched with selected nutrients. Preferred algae extracts are from seaweed, blue-green algae, from the green alga Codium tomentosum and from the brown algae Fucus vesiculosus. A particularly preferred algae extract is from blue-green algae of the species Spirulina, which were cultured in a magnesium-enriched medium.

When Another plant extract particularly preferred are the extracts Spirulina, green tea, aloe vera, meristem, hamamelis, Apricot, guava, sweet potato, lime, mango, Kiwi, cucumber, mallow, marshmallow and violets. The invention Means can be added as an extra plant extract also mixtures of several, especially two, different Contains plant extracts.

When Extractants for the preparation of these plant extracts can for example, water, alcohols and mixtures thereof, oils or other suitable solvents. Among the alcohols are lower alcohols such as ethanol and Isopropanol, but especially polyhydric alcohols such as ethylene glycol, Propylene glycol, dipropylene glycol and butylene glycol both as sole extractant as well as in mixture with water, prefers. Plant extracts based on water / propylene glycol in the ratio 1:10 to 10: 1 have proved to be particularly suitable proved. The steam distillation falls under the invention the preferred extraction methods. The extraction may but if necessary also in the form of dry extraction.

The plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2-80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture. Depending on the choice of extractants, it may be preferable to stabilize the plant extract by adding a solubilizer. Suitable solubilizers are, for. B. Ethoxylation products of optionally hydrogenated vegetable and animal oils. Preferred solubilizers are ethoxylated mono-, di- and triglycerides of C _8-22 fatty acids having from 4 to 50 ethylene oxide units, e.g. Hydrogenated ethoxylated castor oil, olive oil ethoxylate, almond oil ethoxylate, mink oil ethoxylate, polyoxyethylene glycol capryl - / - / capric acid glycerides, polyoxyethylene glycerol monolaurate, and polyoxyethylene glycol coconut fatty acid glycerides.

Regarding the plant extracts usable according to the invention will continue to refer to the extracts in the page 44 of the 3rd edition of the guideline for the ingredient declaration of cosmetic Medium, published by the Industrieverband Körperpflege- and detergent e. V. (IKW), Frankfurt, beginning table are.

The cosmetic or pharmaceutical compositions and in particular the inventively preferred deodorant or Antiperspirant compositions may continue to contain fatty substances contain. Fatty substances are fatty acids, fatty alcohols, natural and synthetic cosmetic oil components as well to understand natural and synthetic waxes, both in solid form as well as liquid in aqueous or oily Dispersion may be present.

As fatty acids can be used linear and / or branched, saturated and / or unsaturated C _8-30 fatty acids. C _10-22 fatty acids are preferred. Examples are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidonic acid, gadoleic acid, behenic acid and erucic acid, and technical mixtures thereof. Particularly preferred is the use of stearic acid. The fatty acids used can carry one or more hydroxyl groups. Preferred examples of these are the α-hydroxy-C ₈ -C ₁₈ -carboxylic acids and 12-hydroxystearic acid. The amount used is 0.1-15 wt .-%, preferably 0.5-10 wt.%, Particularly preferably 1-5 wt .-%, each based on the total composition.

When Fatty alcohols can be used saturated, mono- or polyunsaturated, branched or unbranched Fatty alcohols of 6-30, preferably 10-22, and most preferably 12-22 carbon atoms. Applicable within the meaning of the invention z. As decanol, octanol, octenol, dodecenol, decenol, octadienol, Dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinol alcohol, Stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, Myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, Linoleyl alcohol, linolenyl alcohol and behenyl alcohol, and their Guerbet.

For Pen formulations are often used waxes. When Natural or synthetic waxes can be used according to the invention are solid paraffins or isoparaffins, plant waxes such as candelilla wax, Carnauba wax, esparto wax, japan wax, cork wax, sugar cane wax, Ouricury wax, Kester wax, montan wax, sunflower wax, fruit waxes and animal waxes, such as. B. beeswaxes and other insect waxes, Spermaceti, shellac wax, wool wax and raffia fat, continue Mineral waxes, such as. Ceresin and ozokerite or the petrochemical Waxes, such as B. petrolatum, paraffin waxes, Microwachse polyethylene or polypropylene and polyethylene glycol waxes. It can be beneficial be to use hydrogenated or hydrogenated waxes. Farther are also chemically modified waxes, especially the hard waxes, z. Montan ester waxes, Sasol waxes and hydrogenated jojoba waxes, used.

Also suitable are the mono-, di- and triglycerides of saturated and optionally hydroxylated C _16-30 fatty acids, such as. B. hydrogenated triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil (Cutina ^® HR)), glyceryl monostearate (Cutina ^® MD), glyceryl tribehenate or glyceryl tri-12-hydroxystearate, further synthetic Vollester of fatty acids and glycols (eg. B. Syncrowachs ^®) or polyols having 2-6 C atoms, fatty acid monoalkanolamides having a C _12-22 acyl radical and a C _2-4 alkanol radical, esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of from 1 to 80 ° C Atoms and saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 1 to 80 carbon atoms, including z. Example, synthetic fatty acid fatty alcohol esters such as stearyl stearate or cetyl palmitate, esters of aromatic carboxylic acids, dicarboxylic acids or hydroxycarboxylic acids (eg., 12-hydroxystearic acid) and saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 1 to 80 C Atoms, lactides of long-chain hydroxycarboxylic acids and full esters of fatty alcohols and di- and tricarboxylic acids, eg. As dicetylsuccinate or dicetyl / stearyl adipate, and mixtures of these substances, provided that the individual wax components or their mixture are solid at room temperature.

It is particularly preferred to choose the wax components from the group of esters of saturated, unbranched alkanecarboxylic acids having a chain length of 14 to 44 carbon atoms and saturated, unbranched alcohols of a chain length of 14 to 44 carbon atoms, provided the wax component or the entirety of the wax components are solid at room temperature. Particularly advantageously, the wax components can be selected from the group consisting of C _{16-36 -alkyl} stearates, C _10-40 -alkyl stearates, C _2-40 -alkyl isostearates, C _20-40 -dialkyl esters of dimer acids, C _18-38 -alkylhydroxystearoyl stearates, C _20-40 alkyl erucates are selected, and C _30-50 alkyl beeswax and cetearyl behenate can also be used. Silicone waxes, for example stearyltrimethylsilane / stearyl alcohol, may also be advantageous. Particularly preferred wax components are the esters of saturated, monohydric C ₂₀ -C ₆₀ alcohols, and saturated C ₈ -C ₃₀ -monocarboxylic acids, in particular a C ₂₀ -C ₄₀ alkyl preferred, the Keunen under the name ^® Kesterwachs K82H by the company Koster Inc. is available. The wax or wax components should be solid at 25 ° C, but melt in the range of 35-95 ° C, with a range of 45-85 ° C being preferred.

natural, chemically modified and synthetic waxes can be used alone or used in combination.

The Wax components are in an amount of 0.1 to 40 wt .-%, based to the total composition, preferably 1 to 30 wt .-% and especially 5-25 wt .-%.

The compositions of the invention may further contain at least one nonpolar or polar liquid oil, which may be natural or synthetic. The polar oil component may be selected from vegetable oils, e.g. Example, sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil and the liquid portions of coconut oil and synthetic triglyceride oils, ester oils, that is the esters of C _6-30 fatty acids with C _2-30 fatty alcohols, from dicarboxylic acid esters such as di- n-butyl adipate, di (2-ethylhexyl) adipate and di (2-ethylhexyl) succinate and diol esters such as ethylene glycol dioleate and propylene glycol di (2-ethylhexanoate), from symmetrical, unsymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example described in of the DE-OS 197 56 454 , Glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC), of mono, - di- and tri fatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol, of branched alkanols, for example. B. Guerbet alcohols having a single branch on the carbon atom 2 such as 2-hexyldecanol, 2-octyldodecanol, isotridecanol and isohexadecanol, from alkanediols, eg. B. from Epoxyalkanen with 12-24 C-atoms by ring opening with water available vicinal diols, from ether alcohols, eg. As the monoalkyl ethers of glycerol, ethylene glycol, 1,2-propylene glycol or 1,2-butanediol, from dialkyl ethers having in each case 12-24 carbon atoms, for. Example, the alkyl methyl ethers or di-n-alkyl ethers, each having a total of 12-24 C-atoms, in particular di-n-octyl ether (Cetiol ^® OE ex Cognis), as well as addition products of ethylene oxide and / or propylene oxide to mono- or polyvalent C _3-20 -Alka noles such as butanol and glycerol, z. PPG-3 myristyl ether (Witconol APM ^®), PPG-14 butyl ether (Ucon Fluid ^® AP) PPG-15 stearyl ether (Arlamol ^® E), PPG-9-butyl ether (Breox B25 ^®) and PPG-10 butanediol (Macol ^® 57). The non-polar oil component may be selected from liquid paraffin oils, isoparaffin oils, e.g. Isohexadecane and isoeicosane, from hydrogenated polyalkenes, especially poly-1-decenes (commercially available as Nexbase 2004, 2006 or 2008 FG (Fortum, Belgium)), from synthetic hydrocarbons, e.g. As 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), as well as volatile and nonvolatile silicone oils, the cyclic, such as. As decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane, or may be linear, for. As linear dimethylpolysiloxane, commercially available z. Example under the name Dow Corning ^® 190, 200, 244, 245, 344 or 345 and Baysilon ^® 350 M.

The compositions of the invention may further contain at least one water-soluble alcohol. Water solubility is understood according to the invention that at least 5 wt .-% of the alcohol at 20 ° C clear dissolve or - in the case of long-chain or polymeric alcohols - by heating the solution to 50 ° C to 60 ° C can be brought into solution. Suitable depending on the dosage form monohydric alcohols such. As ethanol, propanol or isopropanol. Also suitable are water-soluble polyols. These include water-soluble diols, triols and higher alcohols and polyethylene glycols. Among the diols are C ₂ -C ₁₂ diols, in particular 1,2-propylene glycol, butylene glycols such. For example, 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, hexanediols such. For example, 1,6-hexanediol. Further preferred are glycerol and especially diglycerol and triglycerol, 1,2,6-hexanetriol and the dipropylene glycol and the polyethylene glycols (PEG) PEG-400, PEG-600, PEG-1000, PEG-1550, PEG-3000 and PEG-4000 ,

The Amount of the alcohol or the alcohol mixture in the inventive Compositions is 1-98 or 1-70 Wt%, and preferably 5-40 or 5-55 wt%, based on the entire composition. According to the invention used both an alcohol and a mixture of several alcohols become.

The Compositions according to the invention can be substantially anhydrous, that is a maximum of 5 wt .-%, preferably at most 1 wt .-% water. In aqueous dosage forms the water content is 5-98 wt .-%, preferably 10-90 and more preferably 15-85 wt .-%, based on the entire composition.

The compositions of the invention may further comprise at least one hydrophilic modified silicone. They allow the formulation of highly transparent compositions, reduce the stickiness and leave a fresh feeling on the skin. Hydrophilically modified silicones are understood according to the invention to mean polyorganosiloxanes having hydrophilic substituents which cause the water solubility of the silicones. According to the invention, water-solubility is understood to mean that at least 2% by weight of the silicone modified with hydrophilic groups dissolve in water at 20 ° C. Corresponding hydrophilic substituents are, for example, hydroxy, polyethylene glycol or polyethylene glycol / polypropylene glycol side chains and ethoxylated ester side chains. According to the invention are preferably suitable hydrophilic modified silicone copolyols, in particular dimethicone copolyols, for example, by Wacker-Chemie under the name Belsil ^® DMC 6031, Belsil ^® DMC 6032, Belsil ^® DMC 6038 or Belsil ^® DMC 3071 VP or Dow Corning under the name DC 2501 are commercially available. Particularly preferably suitable is the use of Belsil® ^® DMC 6038, as it allows the formulation of highly transparent compositions that achieve higher consumer acceptance. As a hydrophilic silicone derivative, it is also possible to use, for example, ABIL EM97 from Degussa / Goldschmidt. According to the invention, it is also possible to use any desired mixture of the silicones mentioned.

The Amount of hydrophilically modified silicone or alcohol mixture in the compositions of the invention 0.5-10% by weight, preferably 1-8% by weight, and especially preferably 2-6 wt .-%, based on the total weight of Composition.

The Compositions according to the invention can continue to contain emulsifiers and / or surfactants. In a special preferred embodiment was this adducts from 10-50 moles of ethylene oxide to linear or branched fatty alcohols with 16-22 carbon atoms, of fatty acids with 12-22 C atoms Fatty acid alkanolamides, to fatty acid monoglycerides, sorbitan fatty acid monoesters, fatty acid alkanolamides, on fatty acid glycerides, e.g. To hardened castor oil, methylglucoside mono-fatty acid esters and mixtures thereof. In principle, however, any other can Emulsifiers and / or surfactants are used.

• – Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare oder verzweigte C₈-C₂₂-Fettalkohole, an C₁₂-C₂₂-Fettsäuren und an C₈-C₁₅-Alkylphenole,
• – C₁₂-C₂₂-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an C₃-C₆-Polyole, insbesondere an Glycerin,
• – Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester, Fettsäurealkanolamide und Fettsäureglucamide,
• – C₈-C₂₂-Alkylmono- und -oligoglycoside und deren ethoxylierte Analoga, wobei Oligomerisierungsgrade von 1,1 bis 5, insbesondere 1,2 bis 2,0, und Glucose als Zuckerkomponente bevorzugt sind,
• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen, z. B. das im Handel erhältliche Produkt Montanov^® 68,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Partialester von Polyolen mit 3-6 Kohlenstoffatomen mit gesättigten C₈-C₂₂-Fettsäuren,
• – Sterole (Sterine). Als Sterole wird eine Gruppe von Steroiden verstanden, die am C-Atom 3 des Steroid-Gerüstes eine Hydroxylgruppe tragen und sowohl aus tierischem Gewebe (Zoosterole) wie auch aus pflanzlichen Fetten (Phytosterole) isoliert werden. Beispiele für Zoosterole sind das Cholesterol und das Lanosterol. Beispiele geeigneter Phytosterole sind Beta-Sitosterol, Stigmasterol, Campesterol und Ergosterol. Auch aus Pilzen und Hefen werden Sterole, die sogenannten Mykosterole, isoliert.
• – Phospholipide, vor allem die Glucose-Phospolipide, die z. B. als Lecithine bzw. Phosphatidylcholine aus z. B. Eidotter oder Pflanzensamen (z. B. Sojabohnen) gewonnen werden,
• – Fettsäureester von Zuckern und Zuckeralkoholen wie Sorbit,
• – Polyglycerine und Polyglycerinderivate, bevorzugt Polyglyceryl-2-dipolyhydroxystearat (Handelsprodukt Dehymuls^® PGPH) und Polyglyceryl-3-diisostearat (Handelsprodukt Lameform^® TGI),
• – Lineare und verzweigte C₈-C₃₀-Fettsäuren und deren Na-, K-, Ammonium-, Ca-, Mg- und Zn-Salze.

Emulsifiers which can be used according to the invention in this sense are, for example

• Addition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide onto linear or branched C ₈ -C ₂₂ -fatty alcohols, on C ₁₂ -C ₂₂ -fatty acids and on C ₈ -C ₁₅ -alkylphenols,
• C ₁₂ -C ₂₂ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto C ₃ -C ₆ -polyols, in particular to glycerol,
• Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,
• C ₈ -C ₂₂ -alkylmono- and -oligoglycosides and their ethoxylated analogues, preference being given to degrees of oligomerization of from 1.1 to 5, in particular from 1.2 to 2.0, and glucose as the sugar component,
• - Mixtures of alkyl (oligo) glucosides and fatty alcohols, eg. As the commercially available product Montanov ^® 68,
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• Partial esters of polyols having 3-6 carbon atoms with saturated C ₈ -C ₂₂ fatty acids,
• - Sterols (sterols). Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are beta-sitosterol, stigmasterol, campesterol and ergosterol. From mushrooms and yeasts sterols, the so-called mycosterols, isolated.
• - Phospholipids, especially the glucose phospholipids, the z. B. as lecithins or phosphatidylcholines from z. Egg yolks or plant seeds (eg soybeans),
• Fatty acid esters of sugars and sugar alcohols such as sorbitol,
• - polyglycerols and polyglycerol, preferably Polyglyceryl-2 dipolyhydroxystearate (Dehymuls ^® PGPH commercial product) and polyglyceryl-3 diisostearate (Lameform ^® TGI commercial product)
• - Linear and branched C ₈ -C ₃₀ fatty acids and their Na, K, ammonium, Ca, Mg and Zn salts.

The agents according to the invention contain the emulsifiers preferably in amounts of 0.1 to 25 wt .-%, in particular 0.5-15 Wt .-%, based on the total agent.

In another, likewise preferred embodiment, at least one ionic emulsifier selected from anionic, zwitterionic, ampholytic and cationic emulsifiers is contained. Preferred anionic emulsifiers are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl esters having 8 to 18 C atoms in the alkyl group and 1 to 6 oxyethyl groups, monoglyceride sulfates, alkyl and Alkenyletherphosphate and protein fatty acid condensates. Zwitterionic emulsifiers carry in the molecule at least one quaternary ammonium group and at least one -COO ^- - or -SO ₃ ^- group. Particularly suitable zwitterionic emulsifiers are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinates, N-acyl-aminopropyl-N, N-dimethylammoniumglycinate and 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline with 8 each to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat.

Ampholytic emulsifiers contain, in addition to a C ₈ -C ₂₄ -alkyl or -acyl group, at least one free amino group and at least one -COOH or -SO ₃ H group in the molecule and can form internal salts. Examples of suitable ampholytic emulsifiers are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group.

The ionic emulsifiers are in an amount of 0.01 to 5 wt .-%, preferably from 0.05 to 3 wt .-% and particularly preferably from 0.1 to 1 wt .-%, based on the total agent included.

• – alkoxylierte Fettsäurealkylester der Formel R¹CO-(OCH₂CHR²)_xOR³, in der R¹CO für einen linearen oder verzweigten, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 Kohlenstoffatomen, R² für Wasserstoff oder Methyl, R³ für lineare oder verzweigte Alkylreste mit 1 bis 4 Kohlenstoffatomen und x für Zahlen von 1 bis 20 steht,
• – Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide und Fettamine,
• – Fettsäure-N-alkylglucamide,
• – C₈-C₂₂-Alkylamin-N-oxide,
• – Alkylpolyglykoside entsprechend der allgemeinen Formel RO-(Z)_x wobei R für eine C₈-C₁₆-Alkylgruppe, Z für Zucker sowie x für die Anzahl der Zuckereinheiten steht. Die erfindungsgemäß verwendbaren Alkylpolyglykoside können lediglich einen bestimmten Alkylrest R enthalten. Üblicherweise werden diese Verbindungen aber ausgehend von natürlichen Fetten und Ölen oder Mineralölen hergestellt. In diesem Fall liegen als Alkylreste R Mischungen entsprechend den Ausgangsverbindungen bzw. entsprechend der jeweiligen Aufarbeitung dieser Verbindungen vor. Besonders bevorzugt sind solche Alkylpolyglykoside, bei denen R im wesentlichen aus C₈- und C₁₀-Alkylgruppen, im wesentlichen aus C₁₂- und C₁₄-Alkylgruppen, im wesentlichen aus C₈- bis C₁₆-Alkylgruppen oder im wesentlichen aus C₁₂- bis C₁₆-Alkylgruppen besteht. Als Zuckerbaustein Z können beliebige Mono- oder Oligosaccharide eingesetzt werden. Üblicherweise werden Zucker mit 5 bzw. 6 Kohlenstoffatomen sowie die entsprechenden Oligosaccharide eingesetzt, beispielsweise Glucose, Fructose, Galactose, Arabinose, Ribose, Xylose, Lyxose, Allose, Altrose, Mannose, Gulose, Idose, Talose und Sucrose. Bevorzugte Zuckerbausteine sind Glucose, Fructose, Galactose, Arabinose und Sucrose; Glucose ist besonders bevorzugt. Die erfindungsgemäß verwendbaren Alkylpolyglykoside enthalten im Schnitt 1,1 bis 5, bevorzugt 1,1 bis 2,0 besonders bevorzugt 1,1 bis 1,8 Zuckereinheiten. Auch die alkoxylierten Homologen der genannten Alkylpolyglykoside können erfindungsgemäß eingesetzt werden. Diese Homologen können durchschnittlich bis zu 10 Ethylenoxid- und/oder Propylenoxideinheiten pro Alkylglykosideinheit enthalten.

Nonionic surfactants which can be used according to the invention are, for example:

• - alkoxylated fatty acid alkyl esters of the formula R ¹ CO- (OCH ₂ CHR ² ) _x OR ³ , in which R ¹ CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R ^{2 is} hydrogen or methyl, R ^{3 represents} linear or branched alkyl radicals having 1 to 4 carbon atoms and x represents numbers from 1 to 20,
• Adducts of ethylene oxide with fatty acid alkanolamides and fatty amines,
• Fatty acid N-alkylglucamides,
• C ₈ -C ₂₂ -alkylamine N-oxides,
• - Alkylpolyglykoside according to the general formula RO- (Z) _x wherein R is a C ₈ -C ₁₆ alkyl group, Z is sugar and x is the number of sugar units. The inventively usable alkylpo lyglycosides can only contain one particular alkyl radical R. Usually, however, these compounds are prepared starting from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the particular work-up of these compounds. Particular preference is given to those alkyl polyglycosides in which R consists essentially of C ₈ and C ₁₀ -alkyl groups, essentially of C ₁₂ and C ₁₄ -alkyl groups, essentially of C ₈ to C ₁₆ -alkyl groups or essentially of C ₁₂ - To C ₁₆ alkyl groups. As sugar building block Z it is possible to use any desired mono- or oligosaccharides. Usually, sugars having 5 or 6 carbon atoms and the corresponding oligosaccharides are used, for example glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose. Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred. The alkyl polyglycosides which can be used according to the invention contain on average 1.1 to 5, preferably 1.1 to 2.0, more preferably 1.1 to 1.8 sugar units. The alkoxylated homologs of said alkyl polyglycosides can also be used according to the invention. These homologs may contain on average up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.

Suitable zwitterionic surfactants are surface-active compounds which carry at least one quaternary ammonium group and at least one -COO ^(-) or -SO ₃ ^(-) group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3 -hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

• – Acylglutamate der Formel
  
  in der R¹CO für einen linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen und 0, 1, 2 oder 3 Doppelbindungen und X für Wasserstoff, ein Alkali- und/oder Erdalkalimetall, Ammonium, Alkylammonium, Alkanolammonium oder Glucammonium steht, beispielsweise Acylglutamate, die sich von Fettsäuren mit 6 bis 22, vorzugsweise 12 bis 18 Kohlenstoffatomen ableiten, wie beispielsweise C_12/14- bzw. C_12/18-Kokosfettsäure, Laurinsäure, Myristinsäure, Palmitinsäure und/oder Stearinsäure, insbesondere Natrium-N-cocoyl- und Natrium-N-stearoyl-L-glutamat,
• – Ester einer hydroxysubstituierten Di- oder Tricarbonsäure der allgemeinen Formel
  
  in der X = H oder eine -CH₂COOR-Gruppe ist, Y = H oder -OH ist unter der Bedingung, dass Y = H ist, wenn X = -CH₂COOR ist, R, R¹ und R² unabhängig voneinander ein Wasserstoffatom, ein Alkali- oder Erdalkalimetallkation, eine Ammoniumgruppe, das Kation einer ammonium-organischen Base oder einen Rest Z bedeuten, der von einer polyhydroxylierten organischen Verbindung stammt, die aus der Gruppe der veretherten(C₆-C₁₈)-Alkylpolysaccharide mit 1 bis 6 monomeren Saccharideinheiten und/oder der veretherten aliphatischen (C₆-C₁₆)-Hydroxyalkylpolyole mit 2 bis 16 Hydroxylresten ausgewählt sind, unter der Maßgabe, daß wenigstens eine der Gruppen R, R¹ oder R² ein Rest Z ist,
• – Ester des Sulfobernsteinsäure-Salzes der allgemeinen Formel
  
  in der R¹ und R² unabhängig voneinander ein Wasserstoffatom, ein Alkali- oder Erdalkalimetallkation, eine Ammoniumgruppe, das Kation einer ammonium-organischen Base oder einen Rest Z bedeuten, der von einer polyhydroxylierten organischen Verbindung stammt, die aus der Gruppe der veretherten (C₆-C₁₈)-Alkylpolysaccharide mit 1 bis 6 monomeren Saccharideinheiten und/oder der veretherten aliphatischen(C₆-C₁₆)-Hydroxyalkylpolyole mit 2 bis 16 Hydroxylresten ausgewählt ist, unter der Maßgabe, daß wenigstens eine der Gruppen R¹ oder R² ein Rest Z ist,
• – Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremonoalkylpolyoxyethylester mit 8 bis 24 C-Atomen in der Alkylgruppe und 1 bis 6 Ethoxygruppen,
• – Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2–15 Molekülen Ethylenoxid und/oder Propylenoxid an Fettalkohole mit 8 bis 22 C-Atomen darstellen,
• – lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen),
• – Ethercarbonsäuren der Formel R-O-(CH₂-CH₂O)_x-CH₂-COOH, in der R eine lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 16 ist,
• – Acylsarcosinate mit einem linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen und 0, 1, 2 oder 3 Doppelbindungen,
• – Acyltaurate mit einem linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen und 0, 1, 2 oder 3 Doppelbindungen,
• – Acylisethionate mit einem linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen und 0, 1, 2 oder 3 Doppelbindungen,
• – lineare Alkansulfonate mit 8 bis 24 C-Atomen,
• – lineare Alpha-Olefinsulfonate mit 8 bis 24 C-Atomen,
• – Alpha-Sulfofettsäuremethylester von Fettsäuren mit 8 bis 30 C-Atomen,
• – Alkylsulfate und Alkylpolyglykolethersulfate der Formel R-O(CH₂-CH₂O)_z-SO₃X, in der R eine bevorzugt lineare Alkylgruppe mit 8 bis 30 C-Atomen, besonders bevorzugt mit 8-18 C-Atomen, z = 0 oder 1 bis 12, besonders bevorzugt 3, und X ein Natrium-, Kalium-, Magnesium-, Zink-, Ammoniumion oder ein Monoalkanol-, Dialkanol- oder Trialkanolammoniumion mit 2 bis 4 Kohlenstoffatomen in der Alkanolgruppe ist, wobei ein besonders bevorzugtes Beispiel Zinkcocoylethersulfat mit einem Ethoxylierungsgrad von z = 3 ist,
• – Gemische oberflächenaktiver Hydroxysulfonate gemäß DE-A-37 25 030 ,
• – sulfatierte Hydroxyalkylpolyethylen- und/oder Hydroxyalkylenpropylenglykolether gemäß DE-A-37 23 354 ,
• – Sulfonate ungesättigter Fettsäuren mit 8 bis 24 C-Atomen und 1 bis 6 Doppelbindungen gemäß DE-A-39 26 344 ,
• – Alkyl- und/oder Alkenyletherphosphate der Formel (V),
  
• – in der R¹ bevorzugt für einen aliphatischen Kohlenwasserstoffrest mit 8 bis 30 Kohlenstoffatomen, R² für Wasserstoff, einen Rest (CH₂CH₂O)_nR¹ oder X, n für Zahlen von 1 bis 10 und X für Wasserstoff, ein Alkali- oder Erdalkalimetall oder NR³R⁴R⁵R⁶, mit R³ bis R⁶ unabhängig voneinander stehend für einen C₁ bis C₄-Kohlenwasserstoffrest, steht,
• – sulfatierte Fettsäurealkylenglykolester der Formel R⁷CO(AlkO)_nSO₃M, in der R⁷CO- für einen linearen oder verzweigten, aliphatischen, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 C-Atomen, Alk für CH₂CH₂, CHCH₃CH₂ und/oder CH₂CHCH₃, n für Zahlen von 0,5 bis 5 und M für ein Kation steht, wie sie in der DE-OS 197 36 906.5 beschrieben sind,
• – Monoglyceridsulfate und Monoglyceridethersulfate der Formel (VI),
  
• – in der R⁶CO für einen linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen, x, y und z in Summe für 0 oder für Zahlen von 1 bis 30, vorzugsweise 2 bis 10, und X für ein Alkali- oder Erdalkalimetall steht. Typische Beispiele für im Sinne der Erfindung geeignete Monoglycerid(ether)sulfate sind die Umsetzungsprodukte von Laurinsäuremonoglycerid, Kokosfettsäuremonoglycerid, Palmitinsäuremonoglycerid, Stearinsäuremonoglycerid, Ölsäuremonoglycerid und Talgfettsäuremonoglycerid sowie deren Ethylenoxidaddukte mit Schwefeltrioxid oder Chlorsulfonsäure in Form ihrer Natriumsalze. Vorzugsweise werden Monoglyceridsulfate der Formel (VI) eingesetzt, in der R⁶CO für einen linearen Acylrest mit 8 bis 18 Kohlenstoffatomen steht.

Suitable anionic surfactants in compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable foaming anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 carbon atoms in the alkanol group,

• - Acylglutamates of the formula
  
  in which R ¹ CO is a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds and X is hydrogen, an alkali and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium, for example acylglutamates, which are derived from fatty acids having 6 to 22, preferably 12 to 18 carbon atoms, such as, for example, C _12/14 or C _12/18 coconut fatty acid, lauric acid, myristic acid, palmitic acid and / or stearic acid, in particular sodium N-cocoyl and sodium N-stearoyl-L-glutamate,
• - Esters of a hydroxy-substituted di- or tricarboxylic acid of the general formula
  
  wherein X is H or a -CH ₂ COOR group, Y is H or -OH is under the condition that Y is H when X is -CH ₂ COOR, R, R ¹ and R ^{2 are} independently a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group of etherified (C ₆ -C ₁₈ ) alkyl polysaccharides with 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₁₆ ) -hydroxyalkylpolyols having 2 to 16 hydroxyl radicals, with the proviso that at least one of the groups R, R ¹ or R ^{2 is} a radical Z,
• - Ester of sulfosuccinic acid salt of the general formula
  
  in which R ¹ and R ² independently of one another denote a hydrogen atom, an alkali metal or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a Z radical derived from a polyhydroxylated organic compound selected from the group of the etherified (C C ₆ -C ₁₈ ) alkyl polysaccharides having from 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₁₆ ) hydroxyalkyl polyols having from 2 to 16 hydroxyl groups, provided that at least one of R ¹ or R ^{2 is selected} a residue Z is,
• Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 ethoxy groups,
• Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols containing 8 to 22 carbon atoms,
• - linear and branched fatty acids with 8 to 30 carbon atoms (soaps),
• Ether carboxylic acids of the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,
• Acylsarcosinates having a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds,
• Acyl taurates having a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds,
• Acyl isethionates having a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds,
• - linear alkanesulfonates having 8 to 24 carbon atoms,
• - linear alpha-olefin sulfonates having 8 to 24 carbon atoms,
• Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 C atoms,
• - Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH ₂ -CH ₂ O) _z -SO ₃ X, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms, more preferably having 8-18 C atoms, z = 0 or 1 to 12, more preferably 3, and X is a sodium, potassium, magnesium, zinc, ammonium or a monoalkanol, dialkanol or Trialkanolammoniumion having 2 to 4 carbon atoms in the alkanol group, with a particularly preferred example of zinc cocoyl ether sulfate with a degree of ethoxylation of z = 3,
• Mixtures of surface active hydroxysulfonates according to DE-A-37 25 030 .
• - Sulfated Hydroxyalkylpolyethylen- and / or Hydroxyalkylenpropylenglykolether according to DE-A-37 23 354 .
• - Sulfonates of unsaturated fatty acids having 8 to 24 carbon atoms and 1 to 6 double bonds according to DE-A-39 26 344 .
• Alkyl and / or alkenyl ether phosphates of the formula (V),
  
• In which R ^{1 is} preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R ^{2 is} hydrogen, a radical (CH ₂ CH ₂ O) _n R ¹ or X, n is from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or NR ³ R ⁴ R ⁵ R ⁶ , where R ³ to R ⁶ independently of one another represent a C ₁ to C ₄ hydrocarbon radical,
• Sulfated fatty acid alkylene glycol esters of the formula R ⁷ CO (AlkO) _n SO ₃ M in which R ^{7 is} CO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms, Alk for CH ₂ CH ₂ , CHCH ₃ CH ₂ and / or CH ₂ CHCH ₃ , n is from 0.5 to 5 and M is a cation as described in the DE-OS 197 36 906.5 are described
• Monoglyceride sulphates and monoglyceride ether sulphates of the formula (VI),
  
• - In which R ⁶ CO is a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers from 1 to 30, preferably 2 to 10, and X is an alkali or alkaline earth metal. Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts. Monoglyceride sulfates of the formula (VI) in which R ⁶ CO is a linear acyl radical having 8 to 18 carbon atoms are preferably used.

Furthermore, the compositions according to the invention may contain at least one protein hydrolyzate or its derivative. Both vegetable and animal protein hydrolysates can be used according to the invention. Animal protein hydrolysates are z. B. elastin, collagen, Kerstin, silk and milk protein protein hydrolysates, which may also be in the form of salts. Vegetable protein hydrolysates, eg. Soy, wheat, almonds, peas, potato and rice protein hydrolysates. Corresponding commercial products are z. B. Diahin ^® (Diamalt) Gluadin ^® (Cognis), Lexein ^® (Innlex) and Crotein ^® (Croda).

At The location of protein hydrolysates can be different obtained amino acid mixtures, on the other hand also individual Amino acids and their physiologically acceptable Salts are used. To the inventively preferred Amino acids include glycine, serine, threonine, cysteine, Asparagine, glutamine, pyroglutamic acid, alanine, valine, Leucine, isoleucine, proline, tryptophan, phenylalanine, methionine, Aspartic acid, glutamic acid, lysine, arginine and histidine, and the zinc salts and the acid addition salts the said amino acids.

Also possible is the use of derivatives of protein hydrolysates, z. In the form of their fatty acid condensation products. Corresponding commercial products are z. B. Lamepon ^® (Cognis), Gluadin ^® (Cognis), Lexein ^® (Inolex), Crolastin ^{® ®} or Crotein (Croda).

Cationized protein hydrolysates can also be used according to the invention, it being possible for the underlying protein hydrolyzate to originate from the animal, from the plant, from marine life forms or from biotechnologically obtained protein hydrolysates. Preference is given to cationic protein hydrolysates whose protein content on which they are based has a molecular weight of from 100 to 25,000 daltons, preferably from 250 to 5,000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of cationic protein hydrolyzates and derivatives used according to the invention, some of the ingredients listed under the INCI names in the International Cosmetic Ingredient Dictionary and Handbook ( seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702 Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Hair Kerstin, Lauryldimonium Hydroxypropyl Hydrolyzed Kerstin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Silk, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Silk Amino Acids, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin. Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.

In The compositions according to the invention are Protein hydrolysates and their derivatives or the amino acids and their derivatives in amounts of up to 10% by weight, based on the total agent, contain. Amounts of from 0.1 to 5% by weight, in particular from 0.1 to 3% by weight, are particularly preferred.

Farther can the compositions of the invention at least one mono-, oligo- or polysaccharide or their derivatives contain.

According to the invention suitable monosaccharides are z. Glucose, fructose, galactose, arabinose, Ri bose, xylose, lyxose, allose, altrose, mannose, gulose, idose and talose, the deoxy sugars fucose and rhamnose as well as amino sugars such as e.g. As glucosamine or galactosamine. Preferred are glucose, fructose, galactose, arabinose and fucose; Glucose is particularly preferred.

According to the invention suitable Oligosaccharides are composed of two to ten monosaccharide units, z. As sucrose, lactose or trehalose. A particularly preferred Oligosaccharide is sucrose. Also particularly preferred the use of honey, which is predominantly glucose and sucrose contains.

Polysaccharides which are suitable according to the invention are composed of more than ten monosaccharide units. Preferred polysaccharides are the starches made from α-D-glucose units and starch degradation products such as amylose, amylopectin and dextrins. Particularly advantageous according to the invention are chemically and / or thermally modified starches, for. Hydroxypropyl starch phosphate, dihydroxypropyldistarch phosphate or the commercial products Dry ^Flo® . Further preferred are dextrans and their derivatives, eg. B. dextran sulfate. Also preferred are nonionic cellulose derivatives such as methylcellulose, hydroxypropylcellulose or hydroxyethylcellulose, as well as cationic cellulose derivatives, e.g. , The commercial products Celquat ^® and Polymer JR ^®, and preferably Celquat ^® H 100, Celquat L 200 and Polymer JR ^{® ®} 400 (Polyquaternium-10) as well as Polyquaternium-24th Further preferred examples are polysaccharides from fucose units, e.g. B. the commercial product Fucogel ^® . Particularly preferred are the polysaccharides composed of amino sugar units, in particular chitins and their deacetylated derivatives, the chitosans, and mucopolysaccharides. The inventively preferred mucopolysaccharides include hyaluronic acid and its derivatives, e.g. As sodium hyaluronate or Dimethylsilanolhyaluronat, and chondroitin and its derivatives, for. B. chondroitin sulfate.

In an advantageous embodiment, the inventive Compositions at least one film-forming, emulsion-stabilizing, thickening or adhesive polymer selected made of natural and synthetic polymers that are cationic, anionic, amphoteric or nonionic.

According to the invention preferred are cationic, anionic and nonionic polymers.

Preferred among the cationic polymers are polysiloxanes having quaternary groups, e.g. , The commercial products Q2-7224 (Dow Corning), Dow Corning ^® 929 Emulsion (with amodimethicone), SM-2059 (General Electric), SLM-55067 (Wacker) and Abil ^® -Quat 3270 and 3272 (Th. Goldschmidt).

Preferred anionic polymers which can support the action of the active ingredient used according to the invention comprise carboxylate and / or sulfonate groups and as monomers, for example, acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid. Very particularly preferred anionic polymers contain 2-acrylamido-2-methylpropanesulfonic acid as the sole monomer or as comonomer, it being possible for the sulfonic acid group to be wholly or partly in salt form. Within this embodiment, it is preferred to use copolymers of at least one anionic monomer and at least one nonionic monomer. With regard to the anionic monomers, reference is made to the substances listed above. Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters. Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with monomers containing sulfonic acid groups. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid groups are wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound has proven to be particularly advantageous in the context of the teaching of the invention. Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.

Further preferred anionic homopolymers and copolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking sites be. Such compounds are for example the commercial products Carbopol ^®. A particularly preferred anionic copolymer contains as monomer 80-98% of an unsaturated, optionally substituted C _3-6 carboxylic acid or its anhydride and 2-20% of optionally substituted acrylic acid esters of saturated C _10-30 carboxylic acids, the copolymer having the can be crosslinked aforementioned crosslinking agents. Corresponding commercial products are Pemulen ^® and Carbopol ^® grades 954, 980, 1342 and ETD 2020 (ex BF Goodrich).

Suitable nonionic polymers include polyvinyl alcohols, which may be partially saponified, for. B. the commercial products Mowiol ^® and vinylpyrrolidone / vinyl ester copolymers and polyvinylpyrrolidones z. B. under the trademark Luviskol ^® (BASF) are sold.

The Compositions according to the invention can furthermore at least one α-hydroxycarboxylic acid or α-ketocarboxylic acid or its ester, lactone or salt form. Suitable α-hydroxycarboxylic acids or α-ketocarboxylic acids are selected from lactic acid, tartaric acid, citric acid, 2-hydroxybutanoic acid, 2,3-dihydroxypropanoic acid, 2-Hydroxypentanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyheptanoic acid, 2-hydroxyoctanoic acid, 2-hydroxydecanoic acid, 2-hydroxydodecanoic acid, 2-hydroxytetradecanoic acid, 2-hydroxyhexadecanoic acid, 2-hydroxyoctadecanoic acid, mandelic acid, 4-hydroxymandelic acid, malic acid, Erythraric, threaric, glucaric, Galactaric acid, mannaric acid, gular acid, 2-hydroxy-2-methylsuccinic acid, gluconic acid, Pyruvic acid, glucuronic acid and galacturonic acid. The esters of said acids are selected from the methyl, ethyl, propyl, isopropyl, butyl, amyl, pentyl, Hexyl, 2-ethylhexyl, octyl, decyl, dodecyl and hexadecyl esters. The α-hydroxycarboxylic acids or α-ketocarboxylic acids or their derivatives are in amounts of 0.1-10 wt .-%, preferably 0.5-5 wt .-%, each based on the total composition, contain.

• – Vitamine, Provitamine und Vitaminvorstufen aus den Gruppen A, C, E und F, insbesondere 3,4-Didehydroretinol (Vitamin A₂), β-Carotin (Provitamin des Vitamin A₁), Ascorbinsäure (Vitamin C), sowie die Palmitinsäureester, Glucoside oder Phosphate der Ascorbinsäure, Tocopherole, insbesondere α-Tocopherol sowie seine Ester, z. B. das Acetat, das Nicotinat, das Phosphat und das Succinat; weiterhin Vitamin F, worunter essentielle Fettsäuren, besonders Linolsäure, Linolensäure und Arachidonsäure, verstanden werden;
• – einen Ester von Retinol (Vitamin A₁) mit einer C_2-18-Carbonsäure, insbesondere Retinylacetat oder Retinylpalmitat.
• – Vitamine, Provitaminen oder Vitaminvorstufen der Vitamin B-Gruppe oder deren Derivate sowie Derivate von 2-Furanon, insbesondere Vitamin B₁ (Thiamin), Vitamin B₂ (Riboflavin), Vitamin B₃ (Nicotinsäure und/oder Nicotinsäureamid), Vitamin B₅ (Pantothensäure und/oder Panthenol), Vitamin B₆ (Pyridoxin, Pyridoxamin und/oder Pyridoxal) und/oder Vitamin B₇ (Biotin),
• – Allantoin,
• – Ceramide und Pseudoceramide,
• – Triterpene, insbesondere Triterpensäuren wie Ursolsäure, Rosmarinsäure, Betulinsäure, Boswelliasäure und Bryonolsäure,
• – Monomere Catechine, besonders Catechin und Epicatechin, Leukoanthocyanidine, Catechinpolymere (Catechin-Gerbstoffe) sowie Gallotannine,
• – Verdickungsmittel, z. B. Gelatine, Pflanzengumme wie Agar-Agar, Guar-Gum, Alginate, Xanthan-Gum, Gummi arabicum, Karaya-Gummi oder Johannisbrotkernmehl, natürliche und synthetische Tone und Schichtsilikate, z. B. Bentonit, Hectorit, Montmorillonit oder Laponite^®, vollsynthetische Hydrokolloide wie z. B. Polyvinylalkohol, und außerdem Ca-, Mg- oder Zn-Seifen von Fettsäuren,
• – Pflanzenglycoside,
• – Strukturanten wie Maleinsäure und Milchsäure,
• – Dimethylisosorbid,
• – Alpha-, beta- sowie gamma-Cyclodextrine, insbesondere zur Stabilisierung von Retinol,
• – Lösungsmittel, Quell- und Penetrationsstoffe wie Ethanol, Isopropanol, Ethylenglykol, Propylenglykol, Propylenglykolmonoethylether, Glycerin und Diethylenglykol, Carbonate, Hydrogencarbonate, Guanidine, Harnstoffe sowie primäre, sekundäre und tertiäre Phosphate
• – Parfümöle, Pigmente sowie Farbstoffe zum Anfärben des Mittels,
• – Substanzen zur Einstellung des pH-Wertes, z. B. α- und β-Hydroxycarbonsäuren,
• – Komplexbildner wie EDTA, NTA, β-Alanindiessigsäure und Phosphonsäuren,
• – Trübungsmittel wie Latex, Styrol/PVP- und Styrol/Acrylamid-Copolymere,
• – Treibmittel wie Propan-Butan-Gemische, N₂O, Dimethylether, CO₂ und Luft,
• – MMP-1-inhibierende Substanzen, insbesondere ausgewählt aus Photolyase und/oder T4 Endonuclease V, Propylgallat, Precocenen, 6-Hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran und 3,4-Dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran,
• – organische, mineralische und/oder modifizierte mineralische Lichtschutzfilter, insbesondere UVA-Filter und/oder UVB-Filter.

The compositions of the invention may contain other active ingredients, auxiliaries and additives, for example:

• Vitamins, provitamins and vitamin precursors from groups A, C, E and F, in particular 3,4-didehydroretinol (vitamin A ₂ ), β-carotene (provitamin of vitamin A ₁ ), ascorbic acid (vitamin C) and the palmitic acid esters, Glucosides or phosphates of ascorbic acid, tocopherols, especially α-tocopherol and its esters, eg. The acetate, the nicotinate, the phosphate and the succinate; vitamin F, which is understood as meaning essential fatty acids, especially linoleic acid, linolenic acid and arachidonic acid;
• An ester of retinol (vitamin A ₁ ) with a C _2-18 carboxylic acid, in particular retinyl acetate or retinyl palmitate.
• - Vitamins, provitamins or vitamin precursors of the vitamin B group or derivatives thereof and derivatives of 2-furanone, in particular vitamin B ₁ (thiamine), vitamin B ₂ (riboflavin), vitamin B ₃ (nicotinic acid and / or nicotinic acid amide), vitamin B ₅ (Pantothenic acid and / or panthenol), vitamin B ₆ (pyridoxine, pyridoxamine and / or pyridoxal) and / or vitamin B ₇ (biotin),
• - allantoin,
• Ceramides and pseudoceramides,
• Triterpenes, in particular triterpenic acids such as ursolic acid, rosmarinic acid, betulinic acid, boswellic acid and bryonolic acid,
• - Monomeric catechins, especially catechin and epicatechin, leucoanthocyanidins, catechin polymers (catechin tannins) and gallotannins,
• - Thickener, z. As gelatin, plant matter such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum or locust bean gum, natural and synthetic clays and phyllosilicates, z. As bentonite, hectorite, montmorillonite or Laponite ^® , fully synthetic hydrocolloids such. Polyvinyl alcohol, and also Ca, Mg or Zn soaps of fatty acids,
• - vegetable glycosides,
• - structurants such as maleic acid and lactic acid,
• - dimethyl isosorbide,
• Alpha, beta and gamma cyclodextrins, in particular for the stabilization of retinol,
• - Solvents, swelling and penetrating agents such as ethanol, isopropanol, ethylene glycol, propylene glycol, propylene glycol monoethyl ether, glycerol and diethylene glycol, carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates
• Perfume oils, pigments and dyes for staining the agent,
• - substances for adjusting the pH, z. B. α- and β-hydroxycarboxylic acids,
• Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,
• Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers,
• Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,
• MMP-1 inhibiting substances, in particular selected from photolyase and / or T4 endonuclease V, propyl gallate, precocenes, 6-hydroxy-7-methoxy-2,2-dimethyl-1 (2H) -benzopyran and 3,4-dihydroxy 6-hy droxy-7-methoxy-2,2-dimethyl-1 (2H) -benzopyran,
• - Organic, mineral and / or modified mineral sunscreen filters, in particular UVA filters and / or UVB filters.

Deodorant or antiperspirant sticks according to the invention may be in gelled form, on anhydrous wax base and based on W / O emulsions and O / W emulsions. Gel sticks can be made on the basis of fatty acid soaps, dibenzylidene sorbitol, N-acyl amino acid amides, 12-hydroxystearic acid and other gel formers. Aerosol sprays, pump sprays, roll-on applications and creams can be described as water-in-oil emulsion, oil-in-water emulsion, silicone oil-in-water emulsion, water-in-oil microemulsion, oil-in-water Microemulsion, silicone oil-in-water microemulsion, anhydrous suspension, alcoholic and hydroalcoholic solution, aqueous gel, and oil. All said compositions may be thickened, for example, on the basis of fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, carbomer and carbopol type polyacrylates, polyacrylamides and polysaccharides, which may be chemically and / or physically modified, and on a base basis of fatty alcohols in combination with hardened triglycerides, especially in combination with hydrogenated castor oil (Cutina ^® HR). The emulsions and microemulsions may be transparent, translucent or opaque.

Liquid and gelatin dosage forms of the compositions of the invention may contain thickening agents, e.g. As cellulose ethers, such as hydroxypropyl cellulose, hydroxyethyl cellulose and methyl hydroxypropyl cellulose, thickening polymers based on polyacrylates, which may be crosslinked, if desired, for. As the Carbopol types or Pemulen ^® products, or based on polyacrylamides or sulfonic acid-containing polyacrylates, eg. B Sepigel ^® 305 or Simulgel® ^® EG, also inorganic thickeners such. B. Bentonite and Hectorite (Laponite ^®).

The compositions of the invention may contain other cosmetically and dermatologically active substances, such as anti-inflammatory substances, solids selected from silicic acids, eg. As Aerosil ^® types, silica gels, silica, clays, z. B. bentonite or kaolin, magnesium aluminum silicates, z. Talc, boron nitride, titanium dioxide, which may if desired be coated, optionally modified starches and starch derivatives, cellulose powders and polymer powders, furthermore plant extracts, protein hydrolysates, vitamins, perfume oils, sebostatics, anti-acne agents and keratolytics.

The Compositions according to the invention can as far as they are liquid, on flexible and absorbent Carrier applied and as a deodorant or antiperspirant wipes or sponges are offered. As flexible and absorbent Carriers within the meaning of the invention are suitable for. B. carrier from textile fibers, collagen or polymeric foams. As textile fibers can both natural fibers such as cellulose (cotton, linen), Silk, wool, regenerated cellulose (viscose, rayon), cellulose derivatives as well as synthetic fibers such. Polyester, polyacrylonitrile, Woven polyamide or polyolefin fibers or mixtures of such fibers or used non-woven. These fibers can too absorbent cotton pads, nonwovens or fabrics or Knitted be processed. Also flexible and absorbent polymeric foams, e.g. As polyurethane foams and polyamide foams are suitable substrates. The substrate can be one, two, three or more have three layers, the individual layers of the same or different materials. each Substrate layer may have a homogeneous or inhomogeneous structure with for example different zones of different density exhibit.

When absorbent in the context of the invention are such carrier substrates to be considered, which at 20 ° C at least 10 wt .-%, based on dry weight, adsorptive or capillary binding to water. But are preferably such carriers, at least 100 wt .-% water adsorptively and bind capillary.

The Equipment of the carrier substrates takes place in the Way that the absorbent, flexible carrier substrates, preferably from textile fibers, collagen or polymeric foams treated with the compositions of the invention or equips and optionally dries.

there can the treatment (equipment) of the carrier substrates by any method, e.g. B. by spraying, dipping and squeezing, soaking or simply by injecting the composition of the invention in the carrier substrates respectively.

Also preferred according to the invention is the dosage form as an aerosol, the cosmetic composition containing a propellant, preferably selected from propane, butane, isobutane, pentane, isopentane, dimethyl ether, fluorohydrocarbons and chlorofluorocarbons. Likewise, a kompri mated propellant such as air, nitrogen or carbon dioxide can be used. Likewise, mixtures of the stated blowing agents can be used.

In a preferred embodiment are the inventive Compositions in the form of a liquid or solid oil-in-water emulsion, Water-in-oil emulsion, multiple emulsion, microemulsion, PIT emulsion or Pickering emulsion, a hydrogel, a lipogel, a single- or multi-phase solution, a foam, a Powder or a mixture with at least one as a medical Adhesive suitable polymer before. The funds can also in anhydrous form, such as an oil or a balm, to be presented. Here, the carrier a vegetable or animal oil, a mineral oil, a synthetic oil or a mixture of such oils be.

In a particular embodiment of the agents according to the invention, the agents are present as microemulsions. In the context of the invention, microemulsions are understood as meaning not only the thermodynamically stable microemulsions but also the so-called "PIT" emulsions. These emulsions are systems with the 3 components water, oil and emulsifier, which are present at room temperature as an oil-in-water emulsion. When these systems are heated, microemulsions form in a certain temperature range (referred to as the phase inversion temperature or "PIT"), which on further heating converts to water-in-oil (W / O) emulsions. Upon subsequent cooling, O / W emulsions are again formed, but they are also present at room temperature as microemulsions or as very finely divided emulsions having an average particle diameter of less than 400 nm and in particular of about 100-300 nm. According to the invention, those micro- or "PIT" emulsions may be preferred which have an average particle diameter of about 200 nm. Details regarding this "PIT emulsions" z. B. the publication Angew. Chem. 97, 655-669 (1985) refer to.

Another preferred subject of the present invention are means for Oral care, including oral, dental and / or denture care products to be understood, the at least one hydroxycinnamic acid and / or a derivative thereof and / or at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives included, included.

The Oral, dental and / or dental prosthesis care agents according to the invention For example, as a mouthwash, gel, liquid Toothbrush lotion, stiff toothpaste, chewing gum, denture cleaner or Denture adhesive cream are present.

For this it is necessary, the active compounds of the invention to incorporate into a suitable carrier.

When Carriers can, for. B. also powdery Preparations or aqueous-alcoholic solutions Serve as mouthwash 0 to 15 wt .-% ethanol, 1 to 1.5% by weight aroma oils and 0.01% to 0.5% by weight sweeteners or as mouthwash concentrates 15 to 60 wt .-% ethanol, 0.05 to 5 wt .-% flavor oils, 0.1 to 3 wt .-% sweeteners and possibly further excipients may contain and before Use to be diluted with water. The concentration The components must be chosen so high that after dilution, the stated lower concentration limits in the application not be fallen below.

When Carriers can also use gels as well as more or less Flowable pastes are made from flexible plastic containers or tubes and using a toothbrush be applied to the teeth. Contain such products higher amounts of humectants and binders or Consistency regulators and polishing components. Furthermore are also in these preparations flavor oils, sweeteners and water included.

When Humectants can z. Glycerin, sorbitol, Xylitol, propylene glycols, Polyethenylenglycole or mixtures of these Polyols, especially those Polyethenylenglycole with molecular weights from 200 to 800 (from 400 to 2000) are used be. Preferred as a humectant sorbitol in an amount of 25-40% by weight.

When Anti-calculus agents and as demineralization inhibitors may be condensed phosphates in the form of their alkali metal salts, preferably be contained in the form of their sodium or potassium salts. The aqueous solutions of these phosphates react alkaline due to hydrolytic effects. By addition of acid is the pH of the mouth, Tooth and / or denture care products to the preferred values set from 7.5-9.

It is also possible to use mixtures of different condensed phosphates or else hydrated salts of condensed phosphates are used. The specified amounts of 2-12% by weight, however, refer to the anhydrous salts. Preferably, the condensed phosphate is a sodium or potassium tripolyphosphate in an amount of 5-10% by weight of the composition.

A preferred active ingredient is a caries-inhibiting fluorine compound, preferably from the group of fluorides or monofluorophosphates in an amount of 0.1-0.5 wt .-% fluorine. Suitable fluorine compounds are, for. As sodium monofluorophosphate (Na ₂ PO ₃ F), potassium monofluorophosphate, sodium or potassium fluoride, tin fluoride or the fluoride of an organic amino compound.

As a binder and consistency regulator serve z. B. natural and synthetic water-soluble polymers such as carrageenan, tragacanth, guar, starch and their non-ionic derivatives such. B. Hydroxypropylguar, hydroxyethyl starch, cellulose ethers such as. As hydroxyethyl cellulose or methyl hydroxypropyl cellulose. Also, agar-agar, xanthan gum, pectins, water-soluble carboxyvinyl polymers (eg. Carbopol ^® types), polyvinyl alcohol, polyvinyl pyrrolidone, high molecular weight polyethylene glycols (molecular weight 10 ³ to 10 ⁶ D). Other substances that are suitable for viscosity control are phyllosilicates such. B. montmorillonite clays, colloidal thickening silicas, e.g. As airgel-silica or fumed silicas.

As polishing components may all heretofore known polishing agent, but preferably precipitated and gel silicas, aluminum hydroxide, aluminum silicate, alumina, alumina trihydrate, insoluble sodium metaphosphate, calcium pyrophosphate, calcium hydrogen phosphate, dicalcium phosphate, chalk, hydroxyapatite, hydrotalcites, talc, magnesium aluminum silicate (Veegum ^®), calcium sulfate, magnesium carbonate, Magnesium oxide, sodium aluminum silicates, e.g. As zeolite A or organic polymers, for. As polymethacrylate, are used. The polishing agents are preferably used in smaller quantities of e.g. B. 1-10 wt .-% used.

The Dental and / or oral care products according to the invention can by adding aromatic oils and sweeteners be improved in their organoleptic properties. As aroma oils all come for oral, dental and / or denture care products common natural and synthetic flavors in Question. Natural flavors can be both in shape the ethereal oils isolated from the drugs as well as the be used from these isolated individual components. Prefers should at least one aroma oil from the group of peppermint oil, Spearmint oil, aniseed oil, caraway oil, Eucalyptus oil, fennel oil, cinnamon oil, geranium oil, Sage oil, thyme oil, marjoram oil, basil oil, Citrus oil, Gaultheria oil or one or more isolated from these synthetically produced components of these oils be included. The main components of these oils are z. Menthol, carvone, anethole, cineole, eugenol, cinnamic aldehyde, geraniol, Citronellol, linalool, salvos, thymol, terpinene, terpinol, methylchavicol and methyl salicylate. Other suitable flavors are z. For example, menthyl acetate, Vanillin, ionone, linalyl acetate, rhodinol and piperitone. As a sweetener are either natural sugars such as sucrose, maltose, Lactose and fructose or synthetic sweeteners such as Saccharin sodium salt, sodium cyclamate or aspartame.

In particular, alkyl and / or alkenyl (oligo) glycosides can be used as surfactants. Their preparation and use as surfactants are, for example U.S. Patent 3,839,318 . US-A-3,707,535 . US-A-3,547,828 DE-A-19 43 689 . DE-A-20 36 472 and DE-A-30 01 064 such as EP-A-77 167 known. With respect to the glycoside, it is true that both monoglycosides (x = 1) in which a pentose or hexose is glycosidically bonded to a primary alcohol having 4 to 16 carbon atoms, as well as oligomeric glycosides having a degree of oligomerization x to 10 are suitable. The degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products.

As alkyl and / or alkenyl (oligo) glycoside, an alkyl and / or alkenyl (oligo) glucoside of the formula RO (C ₈ H ₁₀ O) _x -H in which R is an alkyl radical and is preferably suitable / or alkenyl group having 8 to 14 carbon atoms and x has an average of 1 to 4. Particular preference is given to alkyl oligoglucosides based on hydrogenated C _12/14 coconut oil having a DP of from 1 to 3. The alkyl and / or alkenyl glycoside surfactant can be used very sparingly, with amounts of from 0.005 to 1% by weight already being used. are sufficient.

In addition to the alkyl glucoside surfactants mentioned, other nonionic, ampholytic and cationic surfactants may also be present, for example: fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, monoglyceride ether sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, ether carboxylic acids, fatty acid glucamides, alkylamido betaine and / or protein fatty acid condensates, the latter preferably based on wheat proteins. In particular, to solubilize the usually water-insoluble aroma oils, a non-ionic solubilizer from the group of surface-active compounds may be required. Particularly suitable for this purpose are, for. Example, ethoxylated fatty acid glycerides, oxyethylated Fettsäuresorbitanpartialester or Fettsäurepar tialester of glycerol or sorbitan Oxethylaten. Solubilizers from the group of ethoxylated Fettsäureglyceride include especially addition products of 20 to 60 moles of ethylene oxide with mono- and diglycerides of linear fatty acids having 12 to 18 carbon atoms or triglycerides of hydroxy fatty acids such as oxystearic acid or ricinoleic acid. Further suitable solubilizers are ethoxylated fatty acid sorbitan partial esters; these are preferably addition products of 20 to 60 moles of ethylene oxide with sorbitan monoesters and sorbitan diesters of fatty acids with 12 to 18 carbon atoms. Also suitable solubilizers are fatty acid partial esters of glycerol or sorbitan ethoxylates; these are preferably mono- and diesters of C ₁₂ -C ₁₈ -fatty acids and adducts of 20 to 60 moles of ethylene oxide with 1 mole of glycerol or 1 mole of sorbitol.

The Oral, dental and / or dental prosthesis care agents according to the invention contain preferably as a solubilizer for optionally contained aroma oils addition products from 20 to 60 moles of ethylene oxide to cured or uncured Castor oil (i.e., oxystearic acid or ricinoleic acid triglyceride), glycerol mono- and / or distearate or sorbitan mono- and / or distearate.

• – Pigmente, z. B. Titandioxid, und/oder Farbstoffe
• – pH-Stellmittel und Puffersubstanzen wie z. B. Natriumbicarbonat, Natriumcitrat, Natriumbenzoat, Zitronensäure, Phosphorsäure oder saure Salze, z. B. NaH₂PO₄
• – wundheilende und entzündungshemmende Stoffe wie z. B. Allantoin, Harnstoff, Panthenol, Azulen bzw. Kamillenextrakt
• – weitere gegen Zahnstein wirksame Stoffe wie z. B. Organophosphonate, z. B. Hydroxyethandiphosphonate oder Azacycloheptandiphosphonat
• – Konservierungsstoffe wie z. B. Sorbinsäure-Salze, p-Hydroxybenzoesäure-Ester.
• – Plaque-Inhibitoren wie z. B. Hexachlorophen, Chlorhexidin, Hexetidin, Triclosan, Bromchlorophen, Phenylsalicylsäureester.

Other common additives for oral, dental and / or denture care medium are z. B.

• - Pigments, z. As titanium dioxide, and / or dyes
• - pH adjusting agent and buffer substances such. As sodium bicarbonate, sodium citrate, sodium benzoate, citric acid, phosphoric acid or acid salts, eg. B. NaH ₂ PO ₄
• - wound healing and anti-inflammatory substances such. Allantoin, urea, panthenol, azulene or chamomile extract
• - Other anti-calculus substances such. B. organophosphonates, z. B. Hydroxyethandiphosphonate or Azacycloheptandiphosphonat
• - Preservatives such. B. sorbic acid salts, p-hydroxybenzoic acid esters.
• - Plaque inhibitors such. As hexachlorophene, chlorhexidine, hexetidine, triclosan, bromochlorophene, Phenylsalicylsäureester.

In a particular embodiment is the composition a mouthwash, a mouthwash, a denture cleaner or a denture adhesive.

For according to the invention preferred prosthesis cleaner, in particular prosthesis cleansing tablets and powders are suitable in addition to the already mentioned ingredients for the oral, Dental and / or denture care additionally per-connections such as peroxoborate, peroxomonosulfate or percarbonate. They have the advantage of being next to the bleaching effect at the same time also deodorizing and / or disinfecting act. The use of such Per-connections in denture cleaners is between 0.01 and 10 wt .-%, in particular between 0.5 and 5 wt .-%.

When other ingredients are also enzymes, such as. B. proteases and Carbohydrase, suitable for breaking down proteins and carbohydrates. The pH can be between pH 4 and pH 12, in particular between pH 5 and pH 11 are.

For the prosthesis cleansing tablets in addition to other auxiliaries are necessary, such as agents that cause a bubbling effect, such as. B. CO ₂ releasing substances such as sodium bicarbonate, fillers, z. As sodium sulfate or dextrose, lubricants, for. As magnesium stearate, flow control agents such as colloidal silica and granulating agents, such as the already mentioned high molecular weight polyethylene glycols or polyvinylpyrrolidone.

Denture adhesives Can be used as powders, creams, foils or liquids offered and support the adhesion of the prostheses.

When Active ingredients are natural and synthetic bulking agents suitable. As natural bulking agents are in addition to alginates also plant gums, such. Gum arabic, tragacanth and karaya gum and natural rubber. In particular Alginates and synthetic swelling agents, such as. For example, sodium carboxymethyl cellulose, high molecular weight ethylene oxide copolymers, salts of poly (vinyl ether-co-maleic acid) and polyacrylamides.

When Excipients for pasty and liquid Products are particularly suitable hydrophobic basics, in particular Hydrocarbons, such as White Vaseline (DAB) or paraffin oil.

embodiments

The The following examples are intended to illustrate the invention, without to limit it to.

Example 1: Activity Tests

substances were using a fluorescence-based test for their inhibitory effect against cystathionine beta-lyase (CBL; E.C. 4.4.1.8.) activity of a crude extract from a Stapyhlococcus sp. (Self-isolate Henkel AG and Co. KGaA). That during the test cysteine released from the substrate forms monobromobimane fluorescent complex.

1.1 Preparation of a crude extract from Staphylococcus sp.

• • Cultivation of Staphylococcus sp. on CaSo agar at 37 ° C for about 48 h
• • Wash the cells with Sörensen buffer pH 7.0 (~ 10 ml / 6 plates)
• Pelleting by centrifugation, washing 3 times with souvenir buffer
• • Mechanical digestion of cells in Sörensen buffer (1 ml / g cells) by means of ball mill (Retsch) or FastPrep Cell Disruptor (MP Biomedicals)
• • centrifugation of cell debris
• • Determination of the protein content of the crude extract with a commercial kit, e.g. B. Uptima BC assay
• • Store at -20 ° C

1.2 Photometric assay for CBL activity and evaluation

• • Assay: 0.25 mM benzylcysteine 0.1 mM monobromobimane (Natsch et al., 2004) 50 μl of crude extract from Staphylococcus sp. 2.5 μl inhibitor (for 1% AWK) Add 250 μl to the wells buffer pH 7.5
• • Measurement of CBL activity as an increase in Fluorescence at 460 nm for 30 min. in a fluorimeter (excitation with blue light of 390 nm).
• • Calculation of specific CBL activity as Δ fluorescence / min x mg protein. All readings are given before corrected by blank values (raw extract replaced by buffer).
• • Comparison of specific CBL activities with and without inhibitor (control).

1.3. Results

• AWK: Anwendungskonzentration; SEM: Standardfehler des Mittelwertes

Specific CBL activities of a crude Stapylococcus extract under the influence of various inhibitors relative to the control (mean ± SEM, n = 2-4 independent replicates). inhibitor CBL residual activity Source / Supplier (AWK in% v / v) (%) No inhibitor (control) 100 - Arnica montana extract (1%) 30 ± 2 Arnica tincture # 15027; Rahn, Frankfurt a. M Extract of Spiraea ulmaria (1%) 9 ± 1 Meadowsweet Extract HG; Rahn, Frankfurt a. M. Extract of Hypericum perforatum (1%) 18 ± 0 Hypericum Glycolic Extract; Rahn, Frankfurt a. M. Camellia sinensis extract (1%) 2 ± 0 Tea green Herbasol tincture, Cosmetochem, CH-Steinhausen Gentiana lutea extract (1%) 10 ± 7 Gentian Extract PG, # 2049; Rahn, Frankfurt a. M. Extract of Melissa officinalis (1%) 3 ± 1 Polyplant ME special, Polygon, CH-Olten Extract of Pyrus malus (1%) 0 ± 0 Pomactiv wap, GFN-Selco, Wald-Michelbach; Extract of Lonicera japonica with 2400 ppm chlorogenic acid (1%) 22 ± 2 Actipone Honeysuckle # 102906; Symrise, Holzminden; Extract from Eucommia ulmoides with> 60% chlorogenic acid (0.1%) 3 ± 1 Eucommia ulmoides leaf extract 60%, IMPAG, Offenbach Extract from Eucommia ulmoides with> 80% chlorogenic acid (0.1%) 6 ± 1 Eucommia ulmoides leaf extract 80%; IMPAG, Offenbach Chlorogenic acid (0.1%) 11 ± 2 Roth, Karlsruhe Chlorogenic acid (0.01%) 53 ± 4 Roth, Karlsruhe Chlorogenic acid (0.001%) 70 ± 7 Roth, Karlsruhe Caffeic acid (0.1%) 1 ± 1 Roth, Karlsruhe

• AWK: application concentration; SEM: standard error of the mean value

Further Tests have also shown that there is an excess of deodorant agents (10% v / v in the assay), the effect of the substances used is not negatively influenced.

The Trial results show that already with a very low Amount of caffeic acid almost completely inhibited Cystathionine beta-lyase can be achieved. A comparison those obtained with plant extracts and pure chlorogenic acid Inhibitory rates show that the effects of some extracts are not alone attributed to their chlorogenic acid content may be: When using 1% Lonicera japonica extract amounts the chlorogenic acid content in the assay z. B. 0.006%. comparable Concentrations of pure chlorogenic acid are significantly worse.

something similar This also applies, for example, to the extracts from Arnica montana and Eucommonia ulmoides. Presumably, therefore, are more ingredients the extracts synergistically involved in enzyme inhibition.

Example 2: Formulation Examples

Antiperspirant sticks according to the invention based on an oil-in-water emulsion (amounts in% by weight) Example no. 1 2 3 4 5 6 7 component Cutina ^® AGS 2.5 2.5 - - - 2.5 2.5 Cutina ^® EGMS - - 2.5 2 - - - Cutina ^® PES - - - - 2 - - Cutina ^® FS45 3.5 3.5 3.5 3.5 3.5 3.5 3.5 Eumulgin ^® 62 0.8 0.8 0.8 0.8 0.8 0.8 0.8 Eumulgin ^® B3 0.8 0.8 0.8 0.8 0.8 0.8 0.8 Diisopropyl adipate (Ceraphyl ^® 230) 6 6 6 6 6 6 6 Novata ^® AB 4 4 4 4 4 4 4 Cutina ^® CP 5 5 5 5 5 5 5 Cutina ^® HR 4 4 4 4 4 4 4 Kester wax K62 5 5 5 5 5 5 5 Locron ^® L (ACH solution 50%) 40 40 40 40 40 40 40 Talc Pharma G 10 10 10 10 10 10 10 Perfume 1.2 1.2 1.2 1.2 1.2 1.2 1.2 Sensiva SC 50 - - 0.6 0.6 0.6 0.6 0.6 Tinogard Q 0,025 0.05 0,025 - 0.1 0.1 - Tinogard AS - - 0,025 - - - - 1,2-propanediol 10 10 10 10 10 10 10 Meadowsweet extract 0.05 - 0.1 - 0.01 0.1 - St. John's wort extract - 0.05 - 0.02 0.01 - 0.05 lactose - - - 0.1 0.01 0.1 0.05 glucose - - - 0.1 - - - Water, demineralized 7.125 7.07 6.45 6.88 6.98 6.3 6.5 total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 Formulation Example 8: Antiperspirant Emulsion (O / W) According to the Invention INGREDIENTS Wt .-% - Percentage ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 23.7 STEARETH-2 2.4 STEARETH-21 1.6 PERFUME 1.2 PPG-15 STEARYL ETHER 0.5 ALUMINUM STARCH OCTENYLSUCCINATE 0.1 TOCOPHERYL ACETATE 0.5 caffeic acid 0.1 AQUA ad 100.0

The emulsion according to Formulation Example 8 had a viscosity of 2200 mPas on the first day after preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C ambient temperature and 20 ° C sample temperature; she was filled into a roll-on applicator. Formulation Example 9: Antiperspirant Emulsion (O / W) According to the Invention INGREDIENTS Wt .-% - Percentage ALUMINUM CHLOROHYDRATE 20.00 STEARETH-2 2.30 STEARETH-21 1.50 PERFUME 1.00 PPG-15 STEARYL ETHER 0.50 ALUMINUM STARCH OCTENYLSUCCINATE 0.10 Honeysuckle extract 0.05 ISOPROPYL MYRISTATE 0.10 AQUA ad 100.00

The emulsion according to Formulation Example 9 had a viscosity of 1700 mPas on the first day after preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C ambient temperature and 20 ° C sample temperature; she was filled into a roll-on applicator. Anhydrous surfactant-containing antiperspirant sticks (in parts by weight) 10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9 Silicone oil DC 245 ^® 28 28 23 23 23 38 42 47 31 Eutanol ^® G 16 10 - - 15 10 - 10 - 10 Cetiol ^® OE - 10 15 - - - - - - Ucon ^® fluid AP 5 5 5 5 5 5 5 5 5 Cutina ^® HR 6 6 6 6 6 6 2 5 6 Lorol C 18 ^® 20 20 20 - 20 20 - - 20 Lanette ^® O - - - 20 - - 10 12 - Eumulgin ^® B 3 3 3 3 3 3 3 3 3 - Cutina ^® E 24 PF - - - - 5 - - - - aluminum chlorohydrate 20 20 20 20 20 20 20 - - talc 7.9 7 7.9 7.9 7.95 7.8 7.9 27 26.5 isopulegol 0.1 - - - - - - - - Eugenylglucosid - 1.0 - - - - - - - zinc gluconate - - - 0.1 - - - - - Zinkpyrrolidoncarbonsäure - - - - 0.05 - - - - Zinkcocoylethersulfat - - - - - 0.2 - - - Zinkglycinatmonohydrat - - - - - - 0.1 - - ascorbyl - - - - - - - 1.0 - 2-ethyl hexyl glycerin - - - - - - - - 1.5 Honeysuckle extract 0.05 0.1 - - - - 0.06 0.07 0.09 Meadowsweet extract - - 0.01 0.02 0.03 0.04 - - - lactose - - 0.05 0.05 0.03 0.04 - - - glucose - - 0.01 - - - - - - galactose - - - 0.02 0.01 - - - - Sprayable, translucent antiperspirant microemulsions (in% by weight) 11.1 11.2 11.3 11.4 11.5 11.6 11.7 11.8 11.9 Plantar ^® 1200 1.71 1.71 - 1.71 1.71 - 1.71 1.71 1.71 Plantar ^® 2000 1.14 1.39 2.40 1.14 1.39 2.40 1.14 1.39 1.39 Glycerol monooleate 0.71 0.71 - 0.71 0.71 - 0.71 0.71 0.71 dioctyl 4.00 4.00 0.09 4.00 4.00 0.09 4.00 4.00 4.00 octyldodecanol 1.00 1.00 0.02 1.00 1.00 0.02 1.00 1.00 1.00 perfume oil 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 aluminum chlorohydrate 8.00 5.00 5.00 - - - 8.00 5.00 5.00 1,2-propylene glycol 5.00 5.00 - 5.00 5.00 - 5.00 5.00 5.00 glycerin - - 5.00 - - 5.00 - - - phenoxyethanol 1.0 - - - 1.0 1.0 - - - lactate - 0.2 - - - - - - - hinokitiol - - 0.01 - - - - - - copper gluconate - - - 0.1 - - - - - glycine - - - - - - 0.2 - - phytic acid - - - - - - - 1.0 - tripotassium - - - - - - - - 1.0 Meadowsweet extract 0.05 0.1 - - - - 0.06 0.07 0.09 St. John's wort extract - - 0.01 0.02 0.03 0.04 - - - lactose - - 0.05 0.05 0.03 0.04 - - - glucose - - 0.01 - - - - - - galactose - - - 0.02 0.01 - - - - water ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 Soap-containing pens (in% by weight) 12.1 12.2 12.3 12.4 12.5 12.6 12.7 ethanol 22.5 22.5 22.5 22.5 22.5 22.5 22.5 Cutina ^® FS 45 4.4 4.4 4.4 4.4 4.4 4.4 4.4 1,3 butanediol 31.7 31.7 31.7 31.7 31.7 31.7 31.7 1,2-propylene glycol 21.0 21.0 21.0 21.0 21.0 21.0 21.0 Eutanol ^® G 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Aethoxal ^® B 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Cremophor ^® RH 455 0.05 0.05 0.05 0.05 0.05 0.05 0.05 45% NaOH 1.44 1.44 1.44 1.44 1.44 1.44 1.44 phenoxyethanol 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Sensiva ^® SC 50 0.3 0.3 0.3 0.3 0.3 0.3 0.3 perfume oil 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Eugenylglucosid 1.0 - - - - - - Dequest ^® 2066 - - - 0.2 - - - Green tea extract - 0,015 - - - - - Meadowsweet extract 0.1 0.1 - - - 0.04 0.1 Honeysuckle extract - - 0.01 0.05 0.1 - - lactose - - - 0.05 0.1 - - glucose 0.1 0.02 galactose - - 0.01 - 0.03 - 0.2 phenylethyl - - - - - - 1.0 Water dist. ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 Deodorant in the pump sprayer (in% by weight) 13.1 13.2 13.3 13.4 13.5 13.6 13.7 13.8 Ethanol 96%, (DEP denatured) 55.0 55.0 55.0 55.0 55.0 55.0 55.0 55.0 triethylcitrate 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Cremophor ^® RH 455 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Eucarol ^® AGE-EC 1.0 - - - - - - - Eucarol ^® AGE ET - 0.2 - - - - - - Eucarol ^® AGE-SS - - 1.0 - - - - - Dequest ^® 2016 D - - - - 0.1 - - - caffeic acid 0.05 0.1 - - - - 0.06 0.07 Meadowsweet extract - - 0.01 0.02 0.03 0.04 - - lactose - - 0.05 0.05 0.03 0.04 - - glucose - - 0.01 - - - - - galactose - - - 0.02 0.01 - - - perfume oil 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 water ad 100 Ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 Anhydrous deodorant spray (in% by weight) 14.1 14.2 2-octyldodecanol 0.5 0.5 Ethanol 99%, (DEP denatured) 39 39.45 naringin 0.05 hinokitiol - 0.01 chlorogenic acid 0.1 0.08 n-butane ad 100 ad 100 Antiperspirant roll-on (in% by weight) 15.1 15.2 15.3 Ethanol 96%, (DEP denatured) 30.0 30.0 30.0 Mergital ^® CS 11 2.0 2.0 2.0 Eumulgin ^® B 3 2.0 2.0 2.0 aluminum chlorohydrate 20.0 20.0 20.0 hydroxyethyl 0.5 0.5 0.5 Dermosoft ^® HMA 0.5 - - caffeic acid 0.02 0.1 0.05 perfume oil 0.8 0.8 0.8 water ad 100 ad 100 ad 100 Suspension type antiperspirant spray (in% by weight) 16.1 16.2 16.3 16.4 16.5 DC-245 10.0 10.0 10.0 10.0 10.0 isopropyl 5.0 5.0 5.0 5.0 5.0 Aluminum chlorohydrate powder 5.0 5.0 5.0 5.0 5.0 Aerosil ^® R 972 2.0 2.0 2.0 2.0 2.0 Geraniol-7 EO 0.5 - 0.5 - 0.5 Alutrat ^® - 2.0 - 2.0 - Meadowsweet extract 0.1 - - - 0.04 St. John's wort extract - 0.01 0.05 0.1 - lactose - - 0.05 0.1 - glucose - - 0.1 - 0.02 galactose - 0.03 0.02 - - n-butane ad 100 ad 100 ad 100 ad 100 ad 100

• Antiperspirant wipes (Formulation examples No. 17.1.-17.4)

For the embodiment according to the invention as an antiperspirant cloth, a single-layer substrate of 100% viscose having a weight per unit area of 50 g / ^m.sup.2 with 75 g each of the example emulsions 11.1 or 11.2 or 2.3 per square meter or with 75 g of the exemplary solutions 13.1 and 13.2, respectively applied, cut into cloths of suitable size and packed in sachets. Water-in-oil emulsion sprays component Example 18.1 [% by weight, based on total preparation incl. Propellant gas] Example 18.1 [% by weight, based on W / O emulsion] Example 18.2 [% by weight, based on total preparation incl. Propellant gas] Example 18.2 [% by weight, based on W / O emulsion] Dow Corning 345 Fluid 2.0 12.5 1.0 4.9 1,2-propylene glycol 0.5 3.1 2.0 9.8 Dow Corning 5225 C 3.0 16.9 (oil) 1.9 (emulsifier) 2.5 11.0 (oil) 1.2 (emulsifier) 2-ethylhexyl palmitate 0.5 3.1 0.5 2.4 phenoxyethanol 0.08 0.5 0.1 0.5 Honeysuckle extract 0.016 0.1 0.01 0.05 Water, demineralized 4,904 30.6 7.14 34.85 Microdry 5.0 31.3 7.25 35.3 n-butane 84.0 - 79.5 - W / O emulsion Compact Spray component Example 19.1 [% by weight, based on total preparation incl. Propellant gas] Example 19.1 [% by weight, based on W / O emulsion] Example 19.2 [% by weight, based on total preparation incl. Propellant gas] Example 19.2 [% by weight, based on W / O emulsion] Dow Corning 345 Fluid 0.48 1.6 2,173 4.1 1,2-propylene glycol 1.5 5.0 4,823 9.1 Dow Corning 5225 C 4.2 12.53 (cyclomethicone) 1.47 (emulsifier) 7.42 12.53 (cyclomethicone) 1.47 (emulsifier) Benzoic acid C12-15 alkyl ester 1.38 4.6 - - 2-ethylhexyl palmitate - - 1,192 2.25 Perfume 0.75 2.5 - - phenoxyethanol 0.15 0.5 0.265 0.5 Meadowsweet extract 0.03 0.1 0.027 0.05 Water, demineralized 1.71 5.7 2.12 4.0 Aluminum chlorohydrate, 50% aqueous solution 19.8 66.0 34,98 66.0 n-butane 70.0 - 47.0 -

example composition 19.1 contains an antiperspirant emulsion according to the invention with 9.9 wt .-% aluminum chlorohydrate, based on the weight of propellant-free emulsion. With a spray rate of 0.35 g / s One sprays 0.035 g of antiperspirant per second Active ingredient aluminum chlorohydrate on the skin surface.

Example Composition 19.2 contains an antiperspirant emulsion according to the invention with 17.49% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. With a spray rate of 0.2 g / s is sprayed on the skin surface per second 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate. Liquid tooth cleaning gels example 20.1 20.2 20.3 20.4 20.5 President 12 SPLS 12 - - 12 - President 8 - 12 12 - - Sorbosil AC 39 - - - - 12 Sorbitol (70%) 30 30 70 75 30 Glycerol (86%) 33 33 - - 33 Lipoxol 1550 1 1 1.5 - 1.0 Lipoxol 400 - - - 2.0 - Keltrol F 0.33 0.5 - - 0.5 Cekol 2000 - - 0.5 0.2 - MgSO ₄ .7H ₂ O 0.21 0.21 0.5 0.3 0.21 ZnSO ₄ .7H ₂ O 0.16 0.16 0.16 - 0.16 MnSO ₄ .H ₂ O 0.01 0.01 - - 0.01 Texapon K1296 1.5 1.5 1.5 1.5 1.5 Tego Betain BL 215 0.6 0.6 0.6 0.6 0.6 Tagat S 0.5 0.5 0.5 0.5 0.5 hexetidine 0.03 0.03 0.05 0.04 0.03 triclosan - - - - 0.10 NaF 0.33 0.33 - - 0.32 Na ₂ PO ₃ F - - 1.1 1.0 - Na ₂ HPO ₄ 0.2 0.2 0.2 0.2 0.2 Sodium benzoate 0.5 0.5 - - 0.5 Na saccharinate 0.2 0.2 0.2 0.2 0.2 aromatic oil 1.0 1.0 1.0 1.0 1.0 Ethanol, dye 2.0 2.0 2.0 2.0 2.0 St. John's wort extract 0.3 0.2 - - 0.1 Meadowsweet extract - - 0.2 0.3 0.1 water ad 100 ad 100 ad 100 ad 100 ad 100 List of raw materials used component INCI Supplier / Manufacturer Aethoxal ^® B PPG-5 laureth-5 Cognis Alutrat ^® aluminum citrate Vevy Cekol 2000 Sodium carboxymethylcellulose Metsa Cetiol ^® OE DICAPRYLYL ETHER Cognis Cremophor ^® RH 455 hydrogenated castor oil with 40 EO, propylene glycol-containing BASF Cutina ^® AGS Glycol distearate Cognis Cutina ^® EGMS Glycol Stearate Cognis Cutina ^® PES Pentaerythrityl distearate Cognis Cutina ^® CP Cetyl palmitate Cognis Cutina ^® FS45 Palmitic Acid, Stearic Acid Cognis Cutina ^® HR Hydrogenated Castor Oil Cognis Cutina ^® E 24 PF PEG-20 GLYCERYL STEARATE Cognis ^DC® 245 cyclopentasiloxane Dow Corning Dequest ^® 2016 D 1-Hydroxyethane-1,1-diphosphonic acid tetra-sodium salt, active substance 84% Solutia (Monsanto) Dequest ^® 2066 Diethylenetriamine penta (methylenephosphonic acid) sodium salt, active acid 45-49% Solutia (Monsanto) Dermosoft HMA p-hydroxymandelic acid sodium salt, active substance 95-96% Dr. Straetmans Dow Corning 200 Fluid 5 cst Dimethicone Dow Corning Dow Corning 345 Fluid Cyclomethicone (decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane) Dow Corning Dow Corning 5225 C Formulation Aid Cyclomethicone, PEG / PPG-18/18 Dimethicone in the weight ratio 9: 1 Dow Corning Eucarol ^® AGE-EC-UP Disodium Cocopolyglucose Citrate, Cesalpinia Chemicals 30% active ingredient in water Eucarol ^® AGE-ET-UP Disodium Cocopolyglucose Tartrate, 30% active ingredient in water Cesalpinia Chemicals Eucarol ^® AGE-SS Disodium Cocopolyglucose Sulfosuccinate, 45% active ingredient in water Cesalpinia Chemicals Eumulgin ^® B2 Ceteareth-20 Cognis Eumulgin ^® B3 Ceteareth-30 Cognis Eumulgin ^® B3 CETEARETH-30 Cognis Eutanol ^® G octyldodecanol Cognis Eutanol ^® G 16 2-hexyl decanol Cognis Green tea extract powdery Dragoco Keltrol F Xanthan gum Kelco Kester wax K62 Cetearyl behenate Koster Keunen Lanette ^® O Cetyl / stearyl alcohol in the ratio 1: 1 Cognis Lipoxol 1550 Polyethylene glycol, MW 1550 RWE / DEA Lipoxol 400 Polyethylene glycol, MW 400 RWE / DEA Locron L (50% ACH solution) Aluminum Chlorohydrate Clariant Lorol C 18 ^® stearyl Cognis Mergital ^® CS 11 CETEARETH-11 Cognis Microdry ^® Aluminum Chlorohydrate Reheis Novata ^® AB Cocoglycerides Cognis Plantar ^® 1200 LAURYL GLUCOSIDE, approx. 50% active substance Cognis Plantar ^® 2000 DECYL GLUCOSIDE, approx. 50% active substance Cognis Sensiva ^® SC 50 2-ethyl hexyl glycerin Schälke & Mayr President 12 SPLS Precipitated silica, spec. Surface area (BET): 80 m ² / g Degussa-Huls President 8 Precipitated silica, spec. Surface area (BET): 60 m ² / g Degussa-Huls Sorbosil AC39 precipitated silica Crosfield Tagat S PEG-30 glyceryl stearate Goldschmidt Tego betaine BL 215 Fatty acid amidoalkylbetaine (30%) (cocoamidopropyl betaine) Goldschmidt Texapon K1296 Sodium lauryl sulfate (powder) Cognis Tinogard AS Bumetrizole Ciba Tinogard Q Tris (tetramethylhydroxypiperidinol) citrate Ciba Trilon A. Nitrilotriacetic acid 3 Na BASF Trilon B EDTA-4 Na BASF Trilon ^® M Methylglycinediacetic acid trisodium salt, active substance 39-41% BASF Ucon ^® fluid AP PPG-14 BUTYL ETHER Amerchol (Union Carbide)

QUOTES INCLUDE IN THE DESCRIPTION

This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Cited patent literature

• WO 2006/079934 [0008]
• WO 2005/011716 [0036]
• WO 2005/092279 [0036]
• WO 01/99376 [0042]
• WO 03/039505 [0042]
• DE 19756454 [0068]
• - DE 3725030 A [0082]
• - DE 3723354 A [0082]
• - DE 3926344 A [0082]
• - DE 19736906 [0082]
• US 3839318A [0122]
• US 3707535 A [0122]
• US 3547828 A [0122]
• - DE 1943689 A [0122]
• - DE 2036472 A [0122]
• - DE 3001064 A [0122]
• EP 77167 A [0122]

Cited non-patent literature

• - Natsch et al. (2004) Chemistry and Biodiversity 1, 1058-1072 [0007]
• Troccaz et al. (2004) Chemistry and Biodiversity 1, 1022-1035 [0007]
• Starkenmann et al. (2005) Chemistry and Biodiversity 2, 705-716 [0007]
• - seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702 [0086]
• - "PIT emulsions" z. B. the publication Angew. Chem. 97, 655-669 (1985) [0109]

Claims (19)

Use of at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives and / or a hydroxycinnamic acid and / or a derivative thereof for the prevention or treatment of Body odor, especially in the axillary or oral area. Use of at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives and / or a hydroxycinnamic acid and / or a Derivative thereof for inhibiting cystathionine beta-lyase. Use according to claim 1 or 2, characterized in that the hydroxycinnamic acid is a compound of the general formula (I)

wherein R1 and R2 are independently selected from hydrogen, C _1-6 alkyl, hydroxy and C _1-6 alkoxy. Use according to claim 3, characterized that the hydroxycinnamic acid is caffeic acid (R1 = H, R2 = OH). Use according to claim 1 or 2, characterized that the derivative of hydroxycinnamic acid is a Ester of hydroxycinnamic acid with an alcohol. Use according to claim 5, characterized that the alcohol is a polyhydroxy compound, in particular to the chinsic acid, acts. Use according to claim 6, characterized that the ester is selected chlorogenic acid and Di-Kaffeylchinasäure. Use according to one of the preceding claims, characterized in that the plant extract, the hydroxycinnamic acid and / or a derivative thereof selected is from extracts of Ipomoea purga, Pyrus communis (pear), Pyrus malus (apple), Ocimum basilicum (basil), Thymus vulgaris (thyme), Teucrium scorodonia, Verbena officinalis, Artemisia dracunculus, Thymus serpyllum, Origanum vulgare, Melissa officinalis, Camellia sinensis, gentiana lutea, stachys officinalis, lonicera japonica, Arnica montana, Eucommia ulmoides (gutta-percha), coffee (Coffea arabica), sunflower (Helianthus annuus), damask rose (Rosa damascena), blueberry (Vaccinium corymbosum) and Japanese honeysuckle (Lonicera japonica) and mixtures thereof. Use according to one of claims 1 to 8, characterized in that the use in a cosmetic or pharmaceutical agent. Use according to claim 9, characterized that the cosmetic or pharmaceutical agent is um a deodorant or antiperspirant. Use according to claim 9, characterized that the cosmetic or pharmaceutical agent is um a means of oral care. Cosmetic or pharmaceutical composition for the treatment or prevention of body odor or Halitosis containing at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives contain, and / or a hydroxycinnamic acid and / or a Derivative thereof. Cosmetic or pharmaceutical composition according to claim 12, characterized in that that it is a deodorant or antiperspirant. Cosmetic or pharmaceutical composition according to claim 13, characterized in that the deodorant or Antiperspirant at least one in the axillary area prebiotic active substance selected from plant extracts Picea spp., Pinus sp., Paullinia sp., Panax sp., Lamium sp., Ribes sp., Hibiscus spec., Malva spec., Vitis spec., Daucus spec., Commiphora spec., Simmondsia spec. or Calendula spec., glycerol monoalkyl ether, in particular 1- (2-ethylhexyl) glycerol ether, isopropyl myristate or Ethyl myristate or mixtures thereof. Cosmetic or pharmaceutical composition according to claim 13 or 14, characterized in that the deodorant or antiperspirant at least one further deodorant active ingredient selected from fragrances, odor absorbers, deodorising acting ion exchangers, antimicrobial or germ-inhibiting Substances, other enzyme-inhibiting substances, antioxidants and odor adsorbents contains. Cosmetic or pharmaceutical composition according to claim 15, characterized in that the antimicrobial agent is an aromatic alcohol of the general formula

where R ¹ -R ⁶ = independently of one another represent a hydrogen atom, a linear or branched and optionally substituted C _1-10 -alkyl group or a linear or branched and optionally substituted C _2-10 -alkenyl group, wherein the substituents are each preferably selected are hydroxy and C _1-6 alkoxy, R ⁷ -R ¹¹ = independently of one another represent a hydrogen atom, a halogen atom, in particular chlorine, or a linear or branched and optionally substituted C _1-10 alkyl group, wherein the substituents are preferably selected are of hydroxy and C _1-6 -alkoxy, in particular methoxy, m = 0 or 1, n, o, p = can independently be integers from 0 to 10, where at least one of the values of n, o, p # 0 is. Cosmetic or pharmaceutical composition according to one of claims 13 to 16, characterized that the deodorant or antiperspirant at least one antiperspirant Active substance selected from astringent salts of aluminum, Zirconium, zinc or titanium. Cosmetic or pharmaceutical composition according to claim 12, characterized in that it is an agent for oral care. Use of at least one plant extract selected from meadowsweet extract, St. John's Wort extract and extracts, the hydroxycinnamic acids and / or their derivatives, and / or a hydroxycinnamic acid and / or a derivative thereof for the manufacture of a cosmetic or pharmaceutical composition for treatment or prevention of body odor, especially in the axillary area.